<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="DC pmcid: 7405836 pmid: 3258096900028-20 doi: 10.1128/CMR.00028-20 : Review Coronavirus" exact="Disease" post="2019â€&quot;COVID-19 COVID-19 Dhama et al. https://orcid.org/0000-0001-7469-4752DhamaKuldeepa*https://orcid.org/0000-0003-1040-3746KhanSharunb*TiwariRuchic*https://orcid.org/0000-0002-1947-4463SircarShubhankard*BhatSudiptad*MalikYashpal Singhd*SinghKaram Pala*ChaicumpaWanpene*https://orcid.org/0000-0002-9412-2556Bonilla-AldanaD. Katterinefgh*https://orcid.org/0000-0001-9773-2192Rodriguez-MoralesAlfonso"/>
 <result pre="Pradesh, India[e], Center of Research Excellence on Therapeutic Proteins and" exact="Antibody" post="Engineering, Department of Parasitology, Faculty of Medicine Siriraj Hospital,"/>
 <result pre="las AmÃ©ricas, Sede Pereira, Pereira, Risaralda, Colombia[g], Public Health and" exact="Infection" post="Research Group, Faculty of Health Sciences, Universidad Tecnologica de"/>
 <result pre="of Health Sciences, Universidad Tecnologica de Pereira, Pereira, Colombia[h], Latin" exact="American" post="Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19), Pereira, Risaralda,"/>
 <result pre="Tecnologica de Pereira, Pereira, Colombia[h], Latin American Network of Coronavirus" exact="Disease" post="2019-COVID-19 Research (LANCOVID-19), Pereira, Risaralda, Colombia[i], Grupo de InvestigaciÃ³n"/>
 <result pre="Singh KP, Chaicumpa W, Bonilla-Aldana DK, Rodriguez-Morales AJ. 2020. Coronavirus" exact="disease" post="2019â€&quot;COVID-19. Clin Microbiol Rev 33:e00028-20. https://doi.org/10.1128/CMR.00028-20. epub: 2020-6-6collection: 2020-10pmc-release:"/>
 <result pre="2019â€&quot;COVID-19. Clin Microbiol Rev 33:e00028-20. https://doi.org/10.1128/CMR.00028-20. epub: 2020-6-6collection: 2020-10pmc-release: 2020-6-6334e00028-20(C)" exact="American" post="Society for Microbiology, 2020All Rights Reserved.This article is made"/>
 <result pre="the PMC Open Access Subset for unrestricted noncommercial re-use and" exact="secondary" post="analysis in any form or by any means with"/>
 <result pre="Nipah virus, and coronaviruses (CoVs). Recently, a new type of" exact="viral infection" post="emerged in Wuhan City, China, and initial genomic sequencing"/>
 <result pre="virus, and coronaviruses (CoVs). Recently, a new type of viral" exact="infection" post="emerged in Wuhan City, China, and initial genomic sequencing"/>
 <result pre="novel CoV strain (2019-nCoV), which has now been termed severe" exact="acute" post="respiratory syndrome CoV-2 (SARS-CoV-2). Although coronavirus disease 2019 (COVID-19)"/>
 <result pre="CoV strain (2019-nCoV), which has now been termed severe acute" exact="respiratory" post="syndrome CoV-2 (SARS-CoV-2). Although coronavirus disease 2019 (COVID-19) is"/>
 <result pre="strain (2019-nCoV), which has now been termed severe acute respiratory" exact="syndrome" post="CoV-2 (SARS-CoV-2). Although coronavirus disease 2019 (COVID-19) is suspected"/>
 <result pre="been termed severe acute respiratory syndrome CoV-2 (SARS-CoV-2). Although coronavirus" exact="disease" post="2019 (COVID-19) is suspected to originate from an animal"/>
 <result pre="Nipah virus, and coronaviruses (CoVs). Recently, a new type of" exact="viral infection" post="emerged in Wuhan City, China, and initial genomic sequencing"/>
 <result pre="virus, and coronaviruses (CoVs). Recently, a new type of viral" exact="infection" post="emerged in Wuhan City, China, and initial genomic sequencing"/>
 <result pre="novel CoV strain (2019-nCoV), which has now been termed severe" exact="acute" post="respiratory syndrome CoV-2 (SARS-CoV-2). Although coronavirus disease 2019 (COVID-19)"/>
 <result pre="CoV strain (2019-nCoV), which has now been termed severe acute" exact="respiratory" post="syndrome CoV-2 (SARS-CoV-2). Although coronavirus disease 2019 (COVID-19) is"/>
 <result pre="strain (2019-nCoV), which has now been termed severe acute respiratory" exact="syndrome" post="CoV-2 (SARS-CoV-2). Although coronavirus disease 2019 (COVID-19) is suspected"/>
 <result pre="been termed severe acute respiratory syndrome CoV-2 (SARS-CoV-2). Although coronavirus" exact="disease" post="2019 (COVID-19) is suspected to originate from an animal"/>
 <result pre="such as Ebola virus, avian H7N9, SARS-CoV, and Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV), SARS-CoV-2 has shown relatively low pathogenicity"/>
 <result pre="as Ebola virus, avian H7N9, SARS-CoV, and Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV), SARS-CoV-2 has shown relatively low pathogenicity and"/>
 <result pre="from previous experience with treating SARS-CoV, MERS-CoV, and other emerging" exact="viral" post="diseases. In this review, we address epidemiological, diagnostic, clinical,"/>
 <result pre="past 2 decades, coronaviruses (CoVs) have been associated with significant" exact="disease" post="outbreaks in East Asia and the Middle East. The"/>
 <result pre="outbreaks in East Asia and the Middle East. The severe" exact="acute" post="respiratory syndrome (SARS) and the Middle East respiratory syndrome"/>
 <result pre="in East Asia and the Middle East. The severe acute" exact="respiratory" post="syndrome (SARS) and the Middle East respiratory syndrome (MERS)"/>
 <result pre="East Asia and the Middle East. The severe acute respiratory" exact="syndrome" post="(SARS) and the Middle East respiratory syndrome (MERS) began"/>
 <result pre="The severe acute respiratory syndrome (SARS) and the Middle East" exact="respiratory" post="syndrome (MERS) began to emerge in 2002 and 2012,"/>
 <result pre="severe acute respiratory syndrome (SARS) and the Middle East respiratory" exact="syndrome" post="(MERS) began to emerge in 2002 and 2012, respectively."/>
 <result pre="in 2002 and 2012, respectively. Recently, a novel coronavirus, severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019"/>
 <result pre="2002 and 2012, respectively. Recently, a novel coronavirus, severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19),"/>
 <result pre="and 2012, respectively. Recently, a novel coronavirus, severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2), causing coronavirus disease 2019 (COVID-19), emerged"/>
 <result pre="coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing coronavirus" exact="disease" post="2019 (COVID-19), emerged in late 2019, and it has"/>
 <result pre="Health workers worldwide are currently making efforts to control further" exact="disease" post="outbreaks caused by the novel CoV (originally named 2019-nCoV),"/>
 <result pre="Organization (WHO) announced the official designation for the current CoV-associated" exact="disease" post="to be COVID-19, caused by SARS-CoV-2. The primary cluster"/>
 <result pre="current CoV-associated disease to be COVID-19, caused by SARS-CoV-2. The" exact="primary" post="cluster of patients was found to be connected with"/>
 <result pre="approved vaccines nor specific antiviral drugs for treating human CoV" exact="infections" post="are available (7â€&quot;9). Most nations are currently making efforts"/>
 <result pre="virus by implementing preventive and control strategies. In domestic animals," exact="infections" post="with CoVs are associated with a broad spectrum of"/>
 <result pre="associated with a broad spectrum of pathological conditions. Apart from" exact="infectious" post="bronchitis virus, canine respiratory CoV, and mouse hepatitis virus,"/>
 <result pre="with a broad spectrum of pathological conditions. Apart from infectious" exact="bronchitis" post="virus, canine respiratory CoV, and mouse hepatitis virus, CoVs"/>
 <result pre="spectrum of pathological conditions. Apart from infectious bronchitis virus, canine" exact="respiratory" post="CoV, and mouse hepatitis virus, CoVs are predominantly associated"/>
 <result pre="Apart from infectious bronchitis virus, canine respiratory CoV, and mouse" exact="hepatitis" post="virus, CoVs are predominantly associated with gastrointestinal diseases (10)."/>
 <result pre="of SARS-CoV-2 and the pathogenâ€™s evolution will be helpful for" exact="disease" post="surveillance (12), development of new targeted drugs, and prevention"/>
 <result pre="hemoptysis, and shortness of breath (14). Recently, individuals with asymptomatic" exact="infections" post="were also suspected of transmitting infections, which further adds"/>
 <result pre="of transmitting infections, which further adds to the complexity of" exact="disease" post="transmission dynamics in COVID-19 infections (1). Such efficient responses"/>
 <result pre="adds to the complexity of disease transmission dynamics in COVID-19" exact="infections" post="(1). Such efficient responses require in-depth knowledge regarding the"/>
 <result pre="that the sequence coding for the spike protein, with a" exact="total" post="length of 1,273 amino acids, showed 27 amino acid"/>
 <result pre="afflictions of the lungs in all cases and generated characteristic" exact="chest" post="computer tomography findings, such as the presence of multiple"/>
 <result pre="review describes the various features of SARS-CoV-2/COVID-19 causing the current" exact="disease" post="outbreaks and advances in diagnosis and developing vaccines and"/>
 <result pre="that may extend from the common cold to more severe" exact="respiratory" post="diseases like SARS and MERS (17, 279). The recently"/>
 <result pre="caused a pandemic situation in the worldwide population, leading to" exact="disease" post="outbreaks that have not been controlled to date, although"/>
 <result pre="(25). This virus has been proposed to be designated/named severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee"/>
 <result pre="This virus has been proposed to be designated/named severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on"/>
 <result pre="virus has been proposed to be designated/named severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy"/>
 <result pre="of Viruses (ICTV), which determined the virus belongs to the" exact="Severe" post="acute respiratory syndrome-related coronavirus category and found this virus"/>
 <result pre="Viruses (ICTV), which determined the virus belongs to the Severe" exact="acute" post="respiratory syndrome-related coronavirus category and found this virus is"/>
 <result pre="(ICTV), which determined the virus belongs to the Severe acute" exact="respiratory" post="syndrome-related coronavirus category and found this virus is related"/>
 <result pre="38% (31). These viruses are encircled with an envelope containing" exact="viral" post="nucleocapsid. The nucleocapsids in CoVs are arranged in helical"/>
 <result pre="in CoVs are arranged in helical symmetry, which reflects an" exact="atypical" post="attribute in positive-sense RNA viruses (30). The electron micrographs"/>
 <result pre="while other amplifier hosts might have played a role in" exact="disease" post="transmission to humans (31). Of note, the other two"/>
 <result pre="SARS-CoV-2 and other CoVs is the identification of a novel" exact="short" post="putative protein within the ORF3 band, a secreted protein"/>
 <result pre="Glycoprotein Coronavirus S protein is a large, multifunctional class I" exact="viral" post="transmembrane protein. The size of this abundant S protein"/>
 <result pre="this abundant S protein varies from 1,160 amino acids (IBV," exact="infectious" post="bronchitis virus, in poultry) to 1,400 amino acids (FCoV,"/>
 <result pre="abundant S protein varies from 1,160 amino acids (IBV, infectious" exact="bronchitis" post="virus, in poultry) to 1,400 amino acids (FCoV, feline"/>
 <result pre="appearance. Functionally it is required for the entry of the" exact="infectious" post="virion particles into the cell through interaction with various"/>
 <result pre="(4). Notably, the same nonsynonymous changes were found in a" exact="familial" post="cluster, indicating that the viral evolution happened during person-to-person"/>
 <result pre="changes were found in a familial cluster, indicating that the" exact="viral" post="evolution happened during person-to-person transmission (4, 47). Such adaptive"/>
 <result pre="virus associated with this adaptive evolution, close monitoring of the" exact="viral" post="mutations that occur during subsequent human-to-human transmission is warranted."/>
 <result pre="mutations that occur during subsequent human-to-human transmission is warranted. M" exact="Protein" post="The M protein is the most abundant viral protein"/>
 <result pre="warranted. M Protein The M protein is the most abundant" exact="viral" post="protein present in the virion particle, giving a definite"/>
 <result pre="in the virion particle, giving a definite shape to the" exact="viral" post="envelope (48). It binds to the nucleocapsid and acts"/>
 <result pre="The M protein has three transmembrane domains, flanked by a" exact="short" post="amino terminus outside the virion and a long carboxy"/>
 <result pre="a long carboxy terminus inside the virion (50). Overall, the" exact="viral" post="scaffold is maintained by M-M interaction. Of note, the"/>
 <result pre="amino acid substitution compared to that of SARS-CoV (16). E" exact="Protein" post="The coronavirus E protein is the most enigmatic and"/>
 <result pre="acts as a viroporin (ion channel) (53). The inactivation or" exact="absence of" post="this protein is related to the altered virulence of"/>
 <result pre="to the altered virulence of coronaviruses due to changes in" exact="morphology" post="and tropism (54). The E protein consists of three"/>
 <result pre="(54). The E protein consists of three domains, namely, a" exact="short" post="hydrophilic amino terminal, a large hydrophobic transmembrane domain, and"/>
 <result pre="a similar amino acid constitution without any substitution (16). N" exact="Protein" post="The N protein of coronavirus is multipurpose. Among several"/>
 <result pre="functions, it plays a role in complex formation with the" exact="viral" post="genome, facilitates M protein interaction needed during virion assembly,"/>
 <result pre="(57). The NTD binds with the 3â€² end of the" exact="viral" post="genome, perhaps via electrostatic interactions, and is highly diverged"/>
 <result pre="ORF14) (16). All these proteins play a specific role in" exact="viral" post="replication (27). Unlike the accessory proteins of SARS-CoV, SARS-CoV-2"/>
 <result pre="common origin. However, particular pieces of evidence based on further" exact="complete" post="genomic analysis of current isolates are necessary to draw"/>
 <result pre="single cluster, whereas in Embecovirus, different species, comprised of canine" exact="respiratory" post="CoVs, bovine CoVs, equine CoVs, and human CoV strain"/>
 <result pre="sequence of SARS-CoV (63). As of 13 May 2020, a" exact="total" post="of 4,170,424 confirmed cases of COVID-19 (with 287,399 deaths)"/>
 <result pre="regions with the number of confirmed cases. The WHO region-wise" exact="total" post="number of confirmed cases is depicted in different color"/>
 <result pre="casualties were reported to WHO until 13 May 2020. (B)" exact="Total" post="numbers of deaths and cases in China only. (C)"/>
 <result pre="Total numbers of deaths and cases in China only. (C)" exact="Total" post="number of cases worldwide by region. COVID-19 has also"/>
 <result pre="of the burden associated with COVID-19 in the form of" exact="disease" post="morbidity and mortality (65), but over time the COVID-19"/>
 <result pre="Guangdong Province, China (125â€‰days) (68). Immediately after the confirmation of" exact="viral" post="etiology, the Chinese virologists rapidly released the genomic sequence"/>
 <result pre="The possible origin of SARS-CoV-2 and the first mode of" exact="disease" post="transmission are not yet identified (70). Analysis of the"/>
 <result pre="not yet identified (70). Analysis of the initial cluster of" exact="infections" post="suggests that the infected individuals had a common exposure"/>
 <result pre="well-known for providing different types of wild animals for human" exact="consumption" post="(71). The Huanan South China Seafood Market also sells"/>
 <result pre="expected routes would be associated with transmission, as in other" exact="respiratory" post="viruses, by direct contact, such as shaking contaminated hands,"/>
 <result pre="viruses, higher pathogenicity of a virus is often associated with" exact="lower" post="transmissibility. Compared to emerging viruses like Ebola virus, avian"/>
 <result pre="Ebola virus, avian H7N9, SARS-CoV, and MERS-CoV, SARS-CoV-2 has relatively" exact="lower" post="pathogenicity and moderate transmissibility (15). The risk of death"/>
 <result pre="death among individuals infected with COVID-19 was calculated using the" exact="infection" post="fatality risk (IFR). The IFR was found to be"/>
 <result pre="China have been blamed for the origin of novel coronavirus" exact="infection" post="in humans. Previously, the animals present in the live-animal"/>
 <result pre="present in the live-animal market were identified to be the" exact="intermediate" post="hosts of the SARS outbreak in China (78). Several"/>
 <result pre="sexes are susceptible to COVID-19, older people with an underlying" exact="chronic" post="disease are more likely to become severely infected (80)."/>
 <result pre="are susceptible to COVID-19, older people with an underlying chronic" exact="disease" post="are more likely to become severely infected (80). Recently,"/>
 <result pre="likely to become severely infected (80). Recently, individuals with asymptomatic" exact="infection" post="were also found to act as a source of"/>
 <result pre="infection were also found to act as a source of" exact="infection" post="to susceptible individuals (81). Both the asymptomatic and symptomatic"/>
 <result pre="of infection to susceptible individuals (81). Both the asymptomatic and" exact="symptomatic" post="patients secrete similar viral loads, which indicates that the"/>
 <result pre="individuals (81). Both the asymptomatic and symptomatic patients secrete similar" exact="viral" post="loads, which indicates that the transmission capacity of asymptomatic"/>
 <result pre="which indicates that the transmission capacity of asymptomatic or minimally" exact="symptomatic" post="patients is very high. Thus, SARS-CoV-2 transmission can happen"/>
 <result pre="Thus, SARS-CoV-2 transmission can happen early in the course of" exact="infection" post="(82). Atypical clinical manifestations have also been reported in"/>
 <result pre="transmission can happen early in the course of infection (82)." exact="Atypical" post="clinical manifestations have also been reported in COVID-19 in"/>
 <result pre="the only reporting symptom was fatigue. Such patients may lack" exact="respiratory" post="signs, such as fever, cough, and sputum (83). Hence,"/>
 <result pre="must be on the look-out for the possible occurrence of" exact="atypical" post="clinical manifestations to avoid the possibility of missed diagnosis."/>
 <result pre="active shedding of SARS-CoV-2 in the stool, the prevalence of" exact="infections" post="in a large population can be studied using wastewater-based"/>
 <result pre="wastewater collected from a wastewater treatment plant (327). The calculated" exact="viral" post="RNA copy numbers determine the number of infected individuals."/>
 <result pre="via the fecal route warrants the introduction of negative fecal" exact="viral" post="nucleic acid test results as one of the additional"/>
 <result pre="potential threat to the health of both animals and humans." exact="Advanced" post="studies using Bayesian phylogeographic reconstruction identified the most probable"/>
 <result pre="of the MERS-CoV cases reported in Saudi Arabia are of" exact="secondary" post="origin that occurred through contact with infected asymptomatic or"/>
 <result pre="secondary origin that occurred through contact with infected asymptomatic or" exact="symptomatic" post="individuals through human-to-human transmission (92). The occurrence of superspreading"/>
 <result pre="evaluated. Like SARS and MERS, COVID-19 can also infect the" exact="lower" post="respiratory tract, with milder symptoms (27). The basic reproduction"/>
 <result pre="Like SARS and MERS, COVID-19 can also infect the lower" exact="respiratory" post="tract, with milder symptoms (27). The basic reproduction number"/>
 <result pre="infected cases (84). Coronaviruses in Humansâ€&quot;SARS, MERS, and COVID-19 Coronavirus" exact="infection" post="in humans is commonly associated with mild to severe"/>
 <result pre="infection in humans is commonly associated with mild to severe" exact="respiratory" post="diseases, with high fever, severe inflammation, cough, and internal"/>
 <result pre="was identified, paving the way for severe forms of the" exact="disease" post="in humans (22). Our previous experience with the outbreaks"/>
 <result pre="to the immunopathology of the disease, resulting in impairment of" exact="pulmonary" post="gas exchange. Understanding the interaction between CoVs and host"/>
 <result pre="host innate immune systems could enlighten our understanding of the" exact="lung inflammation" post="associated with this infection (24). SARS is a viral"/>
 <result pre="enlighten our understanding of the lung inflammation associated with this" exact="infection" post="(24). SARS is a viral respiratory disease caused by"/>
 <result pre="lung inflammation associated with this infection (24). SARS is a" exact="viral" post="respiratory disease caused by a formerly unrecognized animal CoV"/>
 <result pre="inflammation associated with this infection (24). SARS is a viral" exact="respiratory" post="disease caused by a formerly unrecognized animal CoV that"/>
 <result pre="associated with this infection (24). SARS is a viral respiratory" exact="disease" post="caused by a formerly unrecognized animal CoV that originated"/>
 <result pre="(24). SARS is a viral respiratory disease caused by a" exact="formerly" post="unrecognized animal CoV that originated from the wet markets"/>
 <result pre="in 2002 to 2003 had 8,098 confirmed cases with 774" exact="total" post="deaths (9.6%) (93). The outbreak severely affected the Asia"/>
 <result pre="though the case fatality rate (CFR) of SARS-CoV-2 (COVID-19) is" exact="lower" post="than that of SARS-CoV, there exists a severe concern"/>
 <result pre="health system, resulting in a pandemic (96). MERS is another" exact="respiratory" post="disease that was first reported in Saudi Arabia during"/>
 <result pre="system, resulting in a pandemic (96). MERS is another respiratory" exact="disease" post="that was first reported in Saudi Arabia during the"/>
 <result pre="first reported in Saudi Arabia during the year 2012. The" exact="disease" post="was found to have a CFR of around 35%"/>
 <result pre="a role in the life cycle of the virus and" exact="disease" post="pathogenicity and might even act as a therapeutic target"/>
 <result pre="than SARS and MERS combined (101). Possibly related to the" exact="viral" post="pathogenesis is the recent finding of an 832-nucleotide (nt)"/>
 <result pre="palm civet for SARS-CoV and the dromedary camel for MERS-CoV" exact="infection" post="(102). Bats are considered the ancestral hosts for both"/>
 <result pre="In the case of COVID-19, there are two possibilities for" exact="primary" post="transmission: it can be transmitted either through intermediate hosts,"/>
 <result pre="possibilities for primary transmission: it can be transmitted either through" exact="intermediate" post="hosts, similar to that of SARS and MERS, or"/>
 <result pre="in circulation maintains specific â€œpoisedâ€� spike proteins that facilitate human" exact="infection" post="without the requirement of any mutations or adaptations (105)."/>
 <result pre="of recombination (107). The current scientific evidence available on MERS" exact="infection" post="suggests that the significant reservoir host, as well as"/>
 <result pre="reservoir host, as well as the animal source of MERS" exact="infection" post="in humans, is the dromedary camels (97). The infected"/>
 <result pre="there is a potential risk for the reemergence of SARS-CoV" exact="infection" post="from the viruses that are currently circulating in the"/>
 <result pre="the bat population (105). CLINICAL PATHOLOGY OF SARS-CoV-2 (COVID-19) The" exact="disease" post="caused by SARS-CoV-2 is also named severe specific contagious"/>
 <result pre="disease caused by SARS-CoV-2 is also named severe specific contagious" exact="pneumonia" post="(SSCP), Wuhan pneumonia, and, recently, COVID-19 (110). Compared to"/>
 <result pre="of COVID-19 cases (111). The incubation period of SARS-CoV-2 in" exact="familial" post="clusters was found to be 3 to 6â€‰days (112)."/>
 <result pre="cough, myalgia or fatigue, and, less commonly, headache, hemoptysis, and" exact="diarrhea" post="(116, 282). Compared to the SARS-CoV-2-infected patients in Wuhan"/>
 <result pre="mast cells, that are present in the submucosa of the" exact="respiratory" post="tract and nasal cavity are considered the primary barrier"/>
 <result pre="of the respiratory tract and nasal cavity are considered the" exact="primary" post="barrier against this virus (92). Advanced in-depth analysis of"/>
 <result pre="cavity are considered the primary barrier against this virus (92)." exact="Advanced" post="in-depth analysis of the genome has identified 380 amino"/>
 <result pre="assessment of lung biopsy samples obtained from COVID-19-infected patients revealed" exact="diffuse" post="alveolar damage, cellular fibromyxoid exudates, hyaline membrane formation, and"/>
 <result pre="exudates, hyaline membrane formation, and desquamation of pneumocytes, indicative of" exact="acute" post="respiratory distress syndrome (119). It was also found that"/>
 <result pre="hyaline membrane formation, and desquamation of pneumocytes, indicative of acute" exact="respiratory" post="distress syndrome (119). It was also found that the"/>
 <result pre="formation, and desquamation of pneumocytes, indicative of acute respiratory distress" exact="syndrome" post="(119). It was also found that the SARS-CoV-2-infected patients"/>
 <result pre="leukocyte abnormalities. The degree of lymphocytopenia gives an idea about" exact="disease" post="prognosis, as it is found to be positively correlated"/>
 <result pre="prognosis, as it is found to be positively correlated with" exact="disease" post="severity (118). Pregnant women are considered to have a"/>
 <result pre="coronaviruses can cause adverse outcomes for the fetus, such as" exact="intrauterine growth restriction," post="spontaneous abortion, preterm delivery, and perinatal death. Nevertheless, the"/>
 <result pre="adverse outcomes for the fetus, such as intrauterine growth restriction," exact="spontaneous abortion," post="preterm delivery, and perinatal death. Nevertheless, the possibility of"/>
 <result pre="raised doubts for the likelihood of vertical transmission (240â€&quot;243). COVID-19" exact="infection" post="was associated with pneumonia, and some developed acute respiratory"/>
 <result pre="(240â€&quot;243). COVID-19 infection was associated with pneumonia, and some developed" exact="acute" post="respiratory distress syndrome (ARDS). The blood biochemistry indexes, such"/>
 <result pre="COVID-19 infection was associated with pneumonia, and some developed acute" exact="respiratory" post="distress syndrome (ARDS). The blood biochemistry indexes, such as"/>
 <result pre="was associated with pneumonia, and some developed acute respiratory distress" exact="syndrome" post="(ARDS). The blood biochemistry indexes, such as albumin, lactate"/>
 <result pre="lymphocytes (percent), and neutrophils (percent) give an idea about the" exact="disease" post="severity in COVID-19 infection (121). During COVID-19, patients may"/>
 <result pre="(percent) give an idea about the disease severity in COVID-19" exact="infection" post="(121). During COVID-19, patients may present leukocytosis, leukopenia with"/>
 <result pre="in COVID-19 infection (121). During COVID-19, patients may present leukocytosis," exact="leukopenia" post="with lymphopenia (244), hypoalbuminemia, and an increase of lactate"/>
 <result pre="infection (121). During COVID-19, patients may present leukocytosis, leukopenia with" exact="lymphopenia" post="(244), hypoalbuminemia, and an increase of lactate dehydrogenase, aspartate"/>
 <result pre="bilirubin, and, especially, D-dimer (244). Middle-aged and elderly patients with" exact="primary" post="chronic diseases, especially high blood pressure and diabetes, were"/>
 <result pre="and, especially, D-dimer (244). Middle-aged and elderly patients with primary" exact="chronic" post="diseases, especially high blood pressure and diabetes, were found"/>
 <result pre="(244). Middle-aged and elderly patients with primary chronic diseases, especially" exact="high blood pressure" post="and diabetes, were found to be more susceptible to"/>
 <result pre="pressure and diabetes, were found to be more susceptible to" exact="respiratory" post="failure and, therefore, had poorer prognoses. Providing respiratory support"/>
 <result pre="susceptible to respiratory failure and, therefore, had poorer prognoses. Providing" exact="respiratory" post="support at early stages improved the disease prognosis and"/>
 <result pre="poorer prognoses. Providing respiratory support at early stages improved the" exact="disease" post="prognosis and facilitated recovery (18). The ARDS in COVID-19"/>
 <result pre="response seen in patients with COVID-19 pneumonia, the bile duct" exact="epithelial" post="cell-derived hepatocytes upregulate ACE2 expression in liver tissue by"/>
 <result pre="IN ANIMALS AND ZOONOTIC LINKSâ€&quot;A BRIEF VIEWPOINT Coronavirus can cause" exact="disease" post="in several species of domestic and wild animals, as"/>
 <result pre="wild animals (20, 30, 79, 93, 124, 125, 287). Coronavirus" exact="infection" post="is linked to different kinds of clinical manifestations, varying"/>
 <result pre="is linked to different kinds of clinical manifestations, varying from" exact="enteritis" post="in cows and pigs, upper respiratory disease in chickens,"/>
 <result pre="of clinical manifestations, varying from enteritis in cows and pigs," exact="upper" post="respiratory disease in chickens, and fatal respiratory infections in"/>
 <result pre="clinical manifestations, varying from enteritis in cows and pigs, upper" exact="respiratory" post="disease in chickens, and fatal respiratory infections in humans"/>
 <result pre="manifestations, varying from enteritis in cows and pigs, upper respiratory" exact="disease" post="in chickens, and fatal respiratory infections in humans (30)."/>
 <result pre="cows and pigs, upper respiratory disease in chickens, and fatal" exact="respiratory" post="infections in humans (30). Among the CoV genera, Alphacoronavirus"/>
 <result pre="and pigs, upper respiratory disease in chickens, and fatal respiratory" exact="infections" post="in humans (30). Among the CoV genera, Alphacoronavirus and"/>
 <result pre="well as from pigs (porcine coronavirus HKU15) (6, 29). Transmissible" exact="gastroenteritis" post="virus (TGEV), porcine epidemic diarrhea virus (PEDV), and porcine"/>
 <result pre="coronavirus HKU15) (6, 29). Transmissible gastroenteritis virus (TGEV), porcine epidemic" exact="diarrhea" post="virus (PEDV), and porcine hemagglutinating encephalomyelitis virus (PHEV) are"/>
 <result pre="virus (TGEV), porcine epidemic diarrhea virus (PEDV), and porcine hemagglutinating" exact="encephalomyelitis" post="virus (PHEV) are some of the coronaviruses of swine."/>
 <result pre="Among them, TGEV and PEDV are responsible for causing severe" exact="gastroenteritis" post="in young piglets with noteworthy morbidity and mortality. Infection"/>
 <result pre="severe gastroenteritis in young piglets with noteworthy morbidity and mortality." exact="Infection" post="with PHEV also causes enteric infection but can cause"/>
 <result pre="noteworthy morbidity and mortality. Infection with PHEV also causes enteric" exact="infection" post="but can cause encephalitis due to its ability to"/>
 <result pre="Infection with PHEV also causes enteric infection but can cause" exact="encephalitis" post="due to its ability to infect the nervous system"/>
 <result pre="due to its ability to infect the nervous system (30)." exact="Bovine" post="coronaviruses (BoCoVs) are known to infect several domestic and"/>
 <result pre="to infect several domestic and wild ruminants (126). BoCoV inflicts" exact="neonatal" post="calf diarrhea in adult cattle, leading to bloody diarrhea"/>
 <result pre="several domestic and wild ruminants (126). BoCoV inflicts neonatal calf" exact="diarrhea" post="in adult cattle, leading to bloody diarrhea (winter dysentery)"/>
 <result pre="and wild ruminants (126). BoCoV inflicts neonatal calf diarrhea in" exact="adult" post="cattle, leading to bloody diarrhea (winter dysentery) and respiratory"/>
 <result pre="inflicts neonatal calf diarrhea in adult cattle, leading to bloody" exact="diarrhea" post="(winter dysentery) and respiratory disease complex (shipping fever) in"/>
 <result pre="in adult cattle, leading to bloody diarrhea (winter dysentery) and" exact="respiratory" post="disease complex (shipping fever) in cattle of all age"/>
 <result pre="adult cattle, leading to bloody diarrhea (winter dysentery) and respiratory" exact="disease" post="complex (shipping fever) in cattle of all age groups"/>
 <result pre="its zoonotic potential as well (127). Feline enteric and feline" exact="infectious" post="peritonitis (FIP) viruses are the two major feline CoVs"/>
 <result pre="zoonotic potential as well (127). Feline enteric and feline infectious" exact="peritonitis" post="(FIP) viruses are the two major feline CoVs (128),"/>
 <result pre="feline CoVs can affect the gastrointestinal tract, abdominal cavity (peritonitis)," exact="respiratory" post="tract, and central nervous system (128). Canines are also"/>
 <result pre="affect the gastrointestinal tract, abdominal cavity (peritonitis), respiratory tract, and" exact="central nervous system" post="(128). Canines are also affected by CoVs that fall"/>
 <result pre="different genera, namely, canine enteric coronavirus in Alphacoronavirus and canine" exact="respiratory" post="coronavirus in Betacoronavirus, affecting the enteric and respiratory tract,"/>
 <result pre="and canine respiratory coronavirus in Betacoronavirus, affecting the enteric and" exact="respiratory" post="tract, respectively (129, 130). IBV, under Gammacoronavirus, causes diseases"/>
 <result pre="losses in chickens (131, 132). In small laboratory animals, mouse" exact="hepatitis" post="virus, rat sialodacryoadenitis coronavirus, and guinea pig and rabbit"/>
 <result pre="pig and rabbit coronaviruses are the major CoVs associated with" exact="disease" post="manifestations like enteritis, hepatitis, and respiratory infections (10, 133)."/>
 <result pre="major CoVs associated with disease manifestations like enteritis, hepatitis, and" exact="respiratory" post="infections (10, 133). Swine acute diarrhea syndrome coronavirus (SADS-CoV)"/>
 <result pre="CoVs associated with disease manifestations like enteritis, hepatitis, and respiratory" exact="infections" post="(10, 133). Swine acute diarrhea syndrome coronavirus (SADS-CoV) was"/>
 <result pre="manifestations like enteritis, hepatitis, and respiratory infections (10, 133). Swine" exact="acute" post="diarrhea syndrome coronavirus (SADS-CoV) was first identified in suckling"/>
 <result pre="like enteritis, hepatitis, and respiratory infections (10, 133). Swine acute" exact="diarrhea" post="syndrome coronavirus (SADS-CoV) was first identified in suckling piglets"/>
 <result pre="enteritis, hepatitis, and respiratory infections (10, 133). Swine acute diarrhea" exact="syndrome" post="coronavirus (SADS-CoV) was first identified in suckling piglets having"/>
 <result pre="coronavirus (SADS-CoV) was first identified in suckling piglets having severe" exact="enteritis" post="and belongs to the genus Alphacoronavirus (106). The outbreak"/>
 <result pre="to their ability to be infected by both human and" exact="avian influenza" post="A viruses (136). Similarly, they may act as the"/>
 <result pre="species. Additionally, pigs are also found to be susceptible to" exact="infection" post="with human SARS-CoV and MERS-CoV, making this scenario a"/>
 <result pre="species. Bats can harbor these viruses without manifesting any clinical" exact="disease" post="but are persistently infected (30). They are the only"/>
 <result pre="(6). This makes them the ideal reservoir host for many" exact="viral" post="agents and also the source of novel coronaviruses that"/>
 <result pre="were identified as significant risks for the emergence of zoonotic" exact="disease" post="in local communities (141, 142). The comprehensive sequence analysis"/>
 <result pre="origin. The recombination was found to have happened within the" exact="viral" post="spike glycoprotein, which recognizes the cell surface receptor. Further"/>
 <result pre="this suggests the potential of pangolins to act as the" exact="intermediate" post="host of SARS-CoV-2 (145). Human-wildlife interactions, which are increasing"/>
 <result pre="the potential of different animal species to act as the" exact="intermediate" post="host of SARS-CoV-2, it was found that both ferrets"/>
 <result pre="of the virus. In addition, infected cats efficiently transmitted the" exact="disease" post="to naive cats (329). SARS-CoV-2 infection and subsequent transmission"/>
 <result pre="cats efficiently transmitted the disease to naive cats (329). SARS-CoV-2" exact="infection" post="and subsequent transmission in ferrets were found to recapitulate"/>
 <result pre="urine, postinfection, making them an ideal animal model for studying" exact="disease" post="transmission (337). Experimental inoculation was also done in other"/>
 <result pre="USDA have reported COVID-19 in tigers and lions that exhibited" exact="respiratory" post="signs like dry cough and wheezing. The zoo animals"/>
 <result pre="to have been infected by an asymptomatic zookeeper (335). The" exact="total" post="number of COVID-19-positive cases in human beings is increasing"/>
 <result pre="increasing at a high rate, thereby creating ideal conditions for" exact="viral" post="spillover to other species, such as pigs. The evidence"/>
 <result pre="focusing on developing and marketing SARS-CoV-2-specific nucleic acid detection kits." exact="Multiple" post="laboratories are also developing their own in-house RT-PCR. One"/>
 <result pre="as of 30 March 2020a Developer Diagnostic platform Centers for" exact="Disease" post="Control and Prevention (CDC) CDC 2019-nCoV real-time RT-PCR diagnostic"/>
 <result pre="diagnostic panel Roche Molecular Systems, Inc. (RMS) cobas SARS-CoV-2 Thermo" exact="Fisher" post="Scientific, Inc. TaqPath COVID-19 combo kit Laboratory Corporation of"/>
 <result pre="COVID-19 RT-PCR test Hologic, Inc. Panther fusion SARS-CoV-2 Quest Diagnostics" exact="Infectious" post="Disease, Inc. Quest SARS-CoV-2 rRT-PCR Quidel Corporation Lyra SARS-CoV-2"/>
 <result pre="Abbott Diagnostics Scarborough, Inc. ID Now COVID-19 Qiagen GmbH QIAstat-Dx" exact="respiratory" post="SARS-CoV-2 panel NeuMoDx Molecular, Inc. NeuMoDx SARS-CoV-2 assay aData"/>
 <result pre="multiple-sequence alignment and phylogenetic analyses for studying variations in the" exact="viral" post="genome (260). All the viral strains revealed high homology"/>
 <result pre="for studying variations in the viral genome (260). All the" exact="viral" post="strains revealed high homology of 99.99% (99.91% to 100%)"/>
 <result pre="levels of diagnostic performance (Table 2) (80, 245, 246). The" exact="viral" post="loads of SARS-CoV-2 were measured using N-gene-specific quantitative RT-PCR"/>
 <result pre="samples collected from COVID-19-infected individuals. The results indicated that the" exact="viral" post="load peaked at around 5 to 6â€‰days following the"/>
 <result pre="107 copies/ml during this time (151). In another study, the" exact="viral" post="load was found to be higher in the nasal"/>
 <result pre="the nasal swabs than the throat swabs obtained from COVID-19" exact="symptomatic" post="patients (82). Although initially it was thought that viral"/>
 <result pre="COVID-19 symptomatic patients (82). Although initially it was thought that" exact="viral" post="load would be associated with poor outcomes, some case"/>
 <result pre="outcomes, some case reports have shown asymptomatic individuals with high" exact="viral" post="loads (247). Recently, the viral load in nasal and"/>
 <result pre="shown asymptomatic individuals with high viral loads (247). Recently, the" exact="viral" post="load in nasal and throat swabs of 17 symptomatic"/>
 <result pre="the viral load in nasal and throat swabs of 17" exact="symptomatic" post="patients was determined, and higher viral loads were recorded"/>
 <result pre="throat swabs of 17 symptomatic patients was determined, and higher" exact="viral" post="loads were recorded soon after the onset of symptoms,"/>
 <result pre="in the nose compared to the throat. The pattern of" exact="viral" post="nucleic acid shedding of SARS-CoV-2-infected patients was similar to"/>
 <result pre="seemed to be different from that of SARS-CoV patients. The" exact="viral" post="load detected in asymptomatic patients resembled that of symptomatic"/>
 <result pre="The viral load detected in asymptomatic patients resembled that of" exact="symptomatic" post="patients as studied in China, which reflects the transmission"/>
 <result pre="in China, which reflects the transmission perspective of asymptomatic or" exact="symptomatic" post="patients having minimum signs and symptoms (82). Another study,"/>
 <result pre="(82). Another study, conducted in South Korea, related to SARS-CoV-2" exact="viral" post="load, opined that SARS-CoV-2 kinetics were significantly different from"/>
 <result pre="including SARS-CoV (253). SARS-CoV-2 transmission can occur early in the" exact="viral infection" post="phase; thus, diagnosing cases and isolation attempts for this"/>
 <result pre="SARS-CoV (253). SARS-CoV-2 transmission can occur early in the viral" exact="infection" post="phase; thus, diagnosing cases and isolation attempts for this"/>
 <result pre="SARS-CoV. Studies are required to establish any correlation between SARS-CoV-2" exact="viral" post="load and cultivable virus. Recognizing patients with fewer or"/>
 <result pre="with fewer or no symptoms, along with having modest detectable" exact="viral" post="RNA in the oropharynx for 5 days, indicates the"/>
 <result pre="+++ Fibrobronchoscope brush biopsy ++ Pharyngeal swabs ++ Feces +" exact="Blood" post="+ Urine + aRecommendations are based on references 245"/>
 <result pre="+, weak. The results of the studies related to SARS-CoV-2" exact="viral" post="loads reflect active replication of this virus in the"/>
 <result pre="viral loads reflect active replication of this virus in the" exact="upper" post="respiratory tract and prolonged viral shedding after symptoms disappear,"/>
 <result pre="loads reflect active replication of this virus in the upper" exact="respiratory" post="tract and prolonged viral shedding after symptoms disappear, including"/>
 <result pre="of this virus in the upper respiratory tract and prolonged" exact="viral" post="shedding after symptoms disappear, including via stool. Thus, the"/>
 <result pre="restraining the SARS-CoV-2 outbreak spread (248). In some cases, the" exact="viral" post="load studies of SARS-CoV-2 have also been useful to"/>
 <result pre="In a recent survey from 17 confirmed cases of SARS-CoV-2" exact="infection" post="with available data (representing days 0 to 13 after"/>
 <result pre="11 after onset) were positive on RT-PCR analysis. Although the" exact="viral" post="loads were lower than those of respiratory samples (range,"/>
 <result pre="were positive on RT-PCR analysis. Although the viral loads were" exact="lower" post="than those of respiratory samples (range, 550 copies per"/>
 <result pre="analysis. Although the viral loads were lower than those of" exact="respiratory" post="samples (range, 550 copies per ml to 1.21â€‰Ã—â€‰105 copies"/>
 <result pre="had traveled from Wuhan to Singapore showed the presence of" exact="viral" post="RNA in stool and whole blood but not in"/>
 <result pre="not in urine by real-time RT-PCR (288). Further, novel SARS-CoV-2" exact="infections" post="have been detected in a variety of clinical specimens,"/>
 <result pre="potent routes of transmission. The correlation of fecal concentrations of" exact="viral" post="RNA with disease severity needs to be determined, along"/>
 <result pre="transmission. The correlation of fecal concentrations of viral RNA with" exact="disease" post="severity needs to be determined, along with assessing the"/>
 <result pre="during the COVID-19 incubation period or convalescence phases of the" exact="disease" post="(249â€&quot;252). The lower respiratory tract sampling techniques, like bronchoalveolar"/>
 <result pre="incubation period or convalescence phases of the disease (249â€&quot;252). The" exact="lower" post="respiratory tract sampling techniques, like bronchoalveolar lavage fluid aspirate,"/>
 <result pre="period or convalescence phases of the disease (249â€&quot;252). The lower" exact="respiratory" post="tract sampling techniques, like bronchoalveolar lavage fluid aspirate, are"/>
 <result pre="with patients (152). Similarly, a single patient with a high" exact="viral" post="load was reported to contaminate an entire endoscopy room"/>
 <result pre="positive results than oral swabs in the later stages of" exact="infection" post="(153). Hence, clinicians have to be cautious while discharging"/>
 <result pre="due to the possibility of fecal-oral transmission. Even though the" exact="viral" post="loads in stool samples were found to be less"/>
 <result pre="stool samples were found to be less than those of" exact="respiratory" post="samples, strict precautionary measures have to be followed while"/>
 <result pre="SARS-CoV-2 in the stool sample. A suspected case of COVID-19" exact="infection" post="is said to be confirmed if the respiratory tract"/>
 <result pre="of COVID-19 infection is said to be confirmed if the" exact="respiratory" post="tract aspirate or blood samples test positive for SARS-CoV-2"/>
 <result pre="RT-PCR or by the identification of SARS-CoV-2 genetic sequence in" exact="respiratory" post="tract aspirate or blood samples (80). The patient will"/>
 <result pre="saliva as a noninvasive specimen for the diagnosis of COVID-19" exact="infection" post="in suspected individuals (152). It has also been observed"/>
 <result pre="with RT-PCR may give negative results even if they have" exact="chest" post="CT findings that are suggestive of infection. Hence, for"/>
 <result pre="is required to prevent the possibility of false-negative results during" exact="disease" post="screening (154). RT-PCR is the most widely used test"/>
 <result pre="clinical perspective, since it will not give any clarity regarding" exact="disease" post="progression. Droplet digital PCR (ddPCR) can be used for"/>
 <result pre="digital PCR (ddPCR) can be used for the quantification of" exact="viral" post="load in the samples obtained from lower respiratory tracts."/>
 <result pre="the quantification of viral load in the samples obtained from" exact="lower" post="respiratory tracts. Hence, based on the viral load, we"/>
 <result pre="quantification of viral load in the samples obtained from lower" exact="respiratory" post="tracts. Hence, based on the viral load, we can"/>
 <result pre="samples obtained from lower respiratory tracts. Hence, based on the" exact="viral" post="load, we can quickly evaluate the progression of infection"/>
 <result pre="the viral load, we can quickly evaluate the progression of" exact="infection" post="(291). In addition to all of the above findings,"/>
 <result pre="critical in the correct identification and confirmation of the causative" exact="viral" post="agent and useful to establish relationships with previous isolates"/>
 <result pre="resources and logistical limitations associated with an outbreak (155). SARS-CoV-2" exact="infection" post="can also be confirmed by isolation and culturing. The"/>
 <result pre="also be confirmed by isolation and culturing. The human airway" exact="epithelial" post="cell culture was found to be useful in isolating"/>
 <result pre="(157). Chest CT is an ideal diagnostic tool for identifying" exact="viral pneumonia." post="The sensitivity of chest CT is far superior to"/>
 <result pre="ideal diagnostic tool for identifying viral pneumonia. The sensitivity of" exact="chest" post="CT is far superior to that of X-ray screening."/>
 <result pre="CT is far superior to that of X-ray screening. The" exact="chest" post="CT findings associated with COVID-19-infected patients include characteristic patchy"/>
 <result pre="later progresses to ground-glass opacities (158). Early manifestations of COVID-19" exact="pneumonia" post="might not be evident in X-ray chest radiography. In"/>
 <result pre="manifestations of COVID-19 pneumonia might not be evident in X-ray" exact="chest" post="radiography. In such situations, a chest CT examination can"/>
 <result pre="be evident in X-ray chest radiography. In such situations, a" exact="chest" post="CT examination can be performed, as it is considered"/>
 <result pre="be performed, as it is considered highly specific for COVID-19" exact="pneumonia" post="(118). Those patients having COVID-19 pneumonia will exhibit the"/>
 <result pre="highly specific for COVID-19 pneumonia (118). Those patients having COVID-19" exact="pneumonia" post="will exhibit the typical ground-glass opacity in their chest"/>
 <result pre="COVID-19 pneumonia will exhibit the typical ground-glass opacity in their" exact="chest" post="CT images (154). The patients infected with COVID-19 had"/>
 <result pre="of angiotensin 2 was found to be linearly associated with" exact="viral" post="load and lung injury, indicating its potential as a"/>
 <result pre="injury, indicating its potential as a diagnostic biomarker (121). The" exact="chest" post="CT imaging abnormalities associated with COVID-19 pneumonia have also"/>
 <result pre="biomarker (121). The chest CT imaging abnormalities associated with COVID-19" exact="pneumonia" post="have also been observed even in asymptomatic patients. These"/>
 <result pre="even in asymptomatic patients. These abnormalities progress from the initial" exact="focal" post="unilateral to diffuse bilateral ground-glass opacities and will further"/>
 <result pre="in asymptomatic patients. These abnormalities progress from the initial focal" exact="unilateral" post="to diffuse bilateral ground-glass opacities and will further progress"/>
 <result pre="patients. These abnormalities progress from the initial focal unilateral to" exact="diffuse" post="bilateral ground-glass opacities and will further progress to or"/>
 <result pre="These abnormalities progress from the initial focal unilateral to diffuse" exact="bilateral" post="ground-glass opacities and will further progress to or coexist"/>
 <result pre="COVID-19 pneumonia. They can also help in the evaluation of" exact="disease" post="severity, identifying its progression to acute respiratory distress syndrome"/>
 <result pre="in the evaluation of disease severity, identifying its progression to" exact="acute" post="respiratory distress syndrome and the presence of secondary bacterial"/>
 <result pre="the evaluation of disease severity, identifying its progression to acute" exact="respiratory" post="distress syndrome and the presence of secondary bacterial infections"/>
 <result pre="of disease severity, identifying its progression to acute respiratory distress" exact="syndrome" post="and the presence of secondary bacterial infections (160). Even"/>
 <result pre="progression to acute respiratory distress syndrome and the presence of" exact="secondary" post="bacterial infections (160). Even though chest CT is considered"/>
 <result pre="to acute respiratory distress syndrome and the presence of secondary" exact="bacterial infections" post="(160). Even though chest CT is considered an essential"/>
 <result pre="acute respiratory distress syndrome and the presence of secondary bacterial" exact="infections" post="(160). Even though chest CT is considered an essential"/>
 <result pre="and the presence of secondary bacterial infections (160). Even though" exact="chest" post="CT is considered an essential diagnostic tool for COVID-19,"/>
 <result pre="Hence, the use of CT for early diagnosis of SARS-CoV-2" exact="infection" post="in high-risk groups should be done with great caution"/>
 <result pre="images (332). Tracking and mapping of the rising incidence rates," exact="disease" post="outbreaks, community spread, clustered transmission events, hot spots, and"/>
 <result pre="and superspreader potential of SARS-CoV-2/COVID warrant full exploitation of real-time" exact="disease" post="mapping by employing geographical information systems (GIS), such as"/>
 <result pre="(CHARMS), which could aid in assessing the possibility of getting" exact="infection" post="and estimating the prognosis in patients; however, such models"/>
 <result pre="present scenario, we need to depend solely on implementing effective" exact="infection" post="control measures to lessen the risk of possible nosocomial"/>
 <result pre="that the major components that have a critical role in" exact="viral" post="entry include PIKfyve, TPC2, and cathepsin L. These findings"/>
 <result pre="our previous experiences in treating SARS-CoV, MERS-CoV, and other emerging" exact="viral" post="diseases. Several therapeutic and preventive strategies, including vaccines, immunotherapeutics,"/>
 <result pre="therapeutic agents against COVID-19 (7, 9, 19, 21, 36). The" exact="primary" post="cause of the unavailability of approved and commercial vaccines,"/>
 <result pre="the requirement for vaccines and therapeutics/drugs exists only for a" exact="limited" post="period, until the outbreak is controlled. The proportion of"/>
 <result pre="human population infected with SARS-CoV and MERS-CoV was also much" exact="lower" post="across the globe, failing to attract drug and vaccine"/>
 <result pre="time an effective drug or vaccine is designed against such" exact="disease" post="outbreaks, the virus would have been controlled by adopting"/>
 <result pre="been evaluated by expressing them in a recombinant parainfluenza virus" exact="type 3" post="vector (BHPIV3). Of note, the result was conclusive that"/>
 <result pre="S protein would not confer any noticeable protection, with the" exact="absence of" post="detectable serum SARS-CoV-neutralizing antibodies (170). Antigenic determinant sites present"/>
 <result pre="responses (176). The recombinant vaccine can be designed by using" exact="rabies" post="virus (RV) as a viral vector. RV can be"/>
 <result pre="can be designed by using rabies virus (RV) as a" exact="viral" post="vector. RV can be made to express MERS-CoV S1"/>
 <result pre="the latter can induce a very high antibody response at" exact="lower" post="doses (167). Hence, the degree of humoral and cellular"/>
 <result pre="vaccines have been getting more popular recently. Among them, the" exact="rabies" post="virus-based vectored vaccine platform is used to develop vaccines"/>
 <result pre="vectored vaccine platform is used to develop vaccines against emerging" exact="infectious diseases." post="The dual vaccine developed from inactivated rabies virus particles"/>
 <result pre="against emerging infectious diseases. The dual vaccine developed from inactivated" exact="rabies" post="virus particles that express the MERS-CoV S1 domain of"/>
 <result pre="was found to induce immune responses for both MERS-CoV and" exact="rabies" post="virus. The vaccinated mice were found to be completely"/>
 <result pre="against MERS spike pseudotyped virus, characterized by the induction of" exact="systemic" post="IgG, secretory IgA, and lung-resident memory T-cell responses (177)."/>
 <result pre="chimpanzee adenovirus-vectored vaccine to counter COVID-19 (180). The Coalition for" exact="Epidemic" post="Preparedness Innovations (CEPI) has initiated three programs to design"/>
 <result pre="Research Center (VRC) of the National Institute of Allergy and" exact="Infectious" post="Diseases (NIAID), part of the National Institutes of Health"/>
 <result pre="Center (VRC) of the National Institute of Allergy and Infectious" exact="Diseases" post="(NIAID), part of the National Institutes of Health (NIH)"/>
 <result pre="like mRNA-1273 SARS-CoV-2 vaccine, INO-4800 DNA coronavirus vaccine, and adenovirus" exact="type 5" post="vector vaccine candidate (Ad5-nCoV), are a few examples under"/>
 <result pre="for live attenuated virus vaccines, formaldehyde alum inactivated vaccine, adenovirus" exact="type 5" post="vector vaccine, LNP-encapsulated mRNA vaccine, DNA plasmid vaccine, and"/>
 <result pre="brought down to 5 years during the Ebola emergency for" exact="viral" post="vector vaccines. In the urgency associated with the COVID-19"/>
 <result pre="requires further investigations. BCG is a widely used vaccine against" exact="tuberculosis" post="in high-risk regions. It is derived from a live"/>
 <result pre="a cohort study was conducted to evaluate the impact of" exact="childhood" post="BCG vaccination in COVID-19 PCR positivity rates. However, childhood"/>
 <result pre="of childhood BCG vaccination in COVID-19 PCR positivity rates. However," exact="childhood" post="BCG vaccination was found to be associated with a"/>
 <result pre="Further studies are required to analyze whether BCG vaccination in" exact="childhood" post="can induce protective effects against COVID-19 in adulthood. Population"/>
 <result pre="(194, 196, 197, 261â€&quot;272). Recently, a clinical trial conducted on" exact="adult" post="patients suffering from severe COVID-19 revealed no benefit of"/>
 <result pre="treatment over standard care (273). The efforts to control SARS-CoV-2" exact="infection" post="utilize defined strategies as followed against MERS and SARS,"/>
 <result pre="hospitals includes mechanical ventilation, intensive care unit (ICU) admittance, and" exact="symptomatic" post="and supportive therapies. Additionally, RNA synthesis inhibitors (lamivudine and"/>
 <result pre="and immunotherapeutic regimens that revealed proven potency in combating other" exact="viral" post="agents similar to SARS-CoV-2. COVID-19 patients showing severe signs"/>
 <result pre="oxygen therapy. In such cases where the patients progress toward" exact="respiratory" post="failure and become refractory to oxygen therapy, mechanical ventilation"/>
 <result pre="refractory to oxygen therapy, mechanical ventilation is necessitated. The COVID-19-induced" exact="septic shock" post="can be managed by providing adequate hemodynamic support (299)."/>
 <result pre="block virus entry into the host cell, drugs that block" exact="viral" post="replication as well as its survival within the host"/>
 <result pre="are available that link NSAID uses with the occurrence of" exact="respiratory" post="and cardiovascular adverse effects. Hence, as a cautionary approach,"/>
 <result pre="that link NSAID uses with the occurrence of respiratory and" exact="cardiovascular" post="adverse effects. Hence, as a cautionary approach, it is"/>
 <result pre="forward to manage critically ill adults suggest the use of" exact="systemic" post="corticosteroids in mechanically ventilated adults with ARDS (303). The"/>
 <result pre="are some concerns associated with the use of corticosteroids in" exact="viral pneumonia." post="Stem cell therapy using mesenchymal stem cells (MSCs) is"/>
 <result pre="(304). Repurposed broad-spectrum antiviral drugs having proven uses against other" exact="viral" post="pathogens can be employed for SARS-CoV-2-infected patients. These possess"/>
 <result pre="specific therapeutic agents against SARS-CoV-2, hospitalized patients confirmed for the" exact="disease" post="are given supportive care, like oxygen and fluid therapy,"/>
 <result pre="oxygen and fluid therapy, along with antibiotic therapy for managing" exact="secondary" post="bacterial infections (192). Patients with novel coronavirus or COVID-19"/>
 <result pre="and fluid therapy, along with antibiotic therapy for managing secondary" exact="bacterial infections" post="(192). Patients with novel coronavirus or COVID-19 pneumonia who"/>
 <result pre="fluid therapy, along with antibiotic therapy for managing secondary bacterial" exact="infections" post="(192). Patients with novel coronavirus or COVID-19 pneumonia who"/>
 <result pre="secondary bacterial infections (192). Patients with novel coronavirus or COVID-19" exact="pneumonia" post="who are mechanically ventilated often require sedatives, analgesics, and"/>
 <result pre="who are mechanically ventilated often require sedatives, analgesics, and even" exact="muscle" post="relaxation drugs to prevent ventilator-related lung injury associated with"/>
 <result pre="Chinese medicine) was found to be effective in managing COVID-19" exact="pneumonia" post="(193). It is difficult to evaluate the therapeutic potential"/>
 <result pre="a drug or a combination of drugs for managing a" exact="disease" post="based on such a limited sample size. Before choosing"/>
 <result pre="of drugs for managing a disease based on such a" exact="limited" post="sample size. Before choosing the ideal therapeutic agent for"/>
 <result pre="revealed remdesivir and chloroquine to be highly effective against SARS-CoV-2" exact="infection" post="in vitro (194). Ribavirin, penciclovir, and favipiravir might not"/>
 <result pre="these nucleoside analogs are needed in vitro to lessen the" exact="viral infection." post="Both remdesivir and chloroquine are being used in humans"/>
 <result pre="novel nucleotide analog prodrug, was developed for treating Ebola virus" exact="disease" post="(EVD), and it was also found to inhibit the"/>
 <result pre="found to inhibit the replication of SARS-CoV and MERS-CoV in" exact="primary" post="human airway epithelial cell culture systems (195). Recently, in"/>
 <result pre="the replication of SARS-CoV and MERS-CoV in primary human airway" exact="epithelial" post="cell culture systems (195). Recently, in vitro study has"/>
 <result pre="conducted in mice also identified that treatment with remdesivir improved" exact="pulmonary" post="function and reduced viral loads and lung pathology both"/>
 <result pre="identified that treatment with remdesivir improved pulmonary function and reduced" exact="viral" post="loads and lung pathology both in prophylactic and therapeutic"/>
 <result pre="prophylactic and therapeutic regimens compared to lopinavir/ritonavir-IFN-Î³ treatment in MERS-CoV" exact="infection" post="(8). Remdesivir also inhibits a diverse range of coronaviruses,"/>
 <result pre="is also considered the only therapeutic drug that significantly reduces" exact="pulmonary" post="pathology (8). All these findings indicate that remdesivir has"/>
 <result pre="further evaluated for its efficacy in the treatment of COVID-19" exact="infection" post="in humans. The broad-spectrum activity exhibited by remdesivir will"/>
 <result pre="activity exhibited by remdesivir will help control the spread of" exact="disease" post="in the event of a new coronavirus outbreak. Chloroquine"/>
 <result pre="both efficacy and safety in the therapeutic management of SARS-CoV-2-associated" exact="pneumonia" post="(197). This drug is already included in the treatment"/>
 <result pre="was found to be associated with a noteworthy reduction in" exact="viral" post="load. Finally, it resulted in a complete cure (271);"/>
 <result pre="noteworthy reduction in viral load. Finally, it resulted in a" exact="complete" post="cure (271); however, the study comprised a small population"/>
 <result pre="drug was able to induce an âˆ¼5,000-fold reduction in the" exact="viral" post="RNA at 48 h in cell culture. (308). One"/>
 <result pre="properties can be modified, thereby having significant control over the" exact="systemic" post="concentration of ivermectin (338). Based on the pharmacokinetic simulation,"/>
 <result pre="pharmacokinetic simulation, it was also found that ivermectin may have" exact="limited" post="therapeutic utility in managing COVID-19, since the inhibitory concentration"/>
 <result pre="the mammalian cell. Therefore, the administration of ivermectin, even at" exact="lower" post="doses, will reduce the viral load at a minor"/>
 <result pre="administration of ivermectin, even at lower doses, will reduce the" exact="viral" post="load at a minor level. This slight decrease will"/>
 <result pre="and hydroxychloroquine might have a synergistic effect, since ivermectin reduces" exact="viral" post="replication, while hydroxychloroquine inhibits the entry of the virus"/>
 <result pre="does not have any sort of inhibitory action against SARS-CoV-2" exact="infection" post="(194). Recently, several newly synthesized halogenated triazole compounds were"/>
 <result pre="Monoclonal antibodies (MAbs) may be helpful in the intervention of" exact="disease" post="in CoV-exposed individuals. Patients recovering from SARS showed robust"/>
 <result pre="recovering from SARS showed robust neutralizing antibodies against this CoV" exact="infection" post="(164). A set of MAbs aimed at the MERS-CoV"/>
 <result pre="virus proteins. Such examples include transbodies to the influenza virus," exact="hepatitis C" post="virus, Ebola virus, and dengue virus (206). Producing similar"/>
 <result pre="study on five grimly sick patients having symptoms of severe" exact="pneumonia" post="due to COVID-19, convalescent plasma administration was found to"/>
 <result pre="efficacy (311). Potential Therapeutic Agents Potent therapeutics to combat SARS-CoV-2" exact="infection" post="include virus binding molecules, molecules or inhibitors targeting particular"/>
 <result pre="replication and transcription process of the virus, helicase inhibitors, vital" exact="viral" post="proteases and proteins, protease inhibitors of host cells, endocytosis"/>
 <result pre="proteases and proteins, protease inhibitors of host cells, endocytosis inhibitors," exact="short" post="interfering RNA (siRNA), neutralizing antibodies, MAbs against the host"/>
 <result pre="randomized animal or human trials. Therefore, they might be of" exact="limited" post="applicability and require trials against SARS-CoV-2 to gain practical"/>
 <result pre="binding of SARS-CoV-2 with ACE2 leads to the exacerbation of" exact="pneumonia" post="as a consequence of the imbalance in the renin-angiotensin"/>
 <result pre="of the imbalance in the renin-angiotensin system (RAS). The virus-induced" exact="pulmonary" post="inflammatory responses may be reduced by the administration of"/>
 <result pre="inhibitors of MERS-CoV (chlorpromazine, chloroquine, loperamide, and lopinavir) that inhibited" exact="viral" post="replication. These compounds also hinder SARS-CoV and human CoVs"/>
 <result pre="the host inflammatory responses. Such drugs acting specifically in the" exact="respiratory" post="tract will help to reduce virus-triggered immune pathologies in"/>
 <result pre="like ibuprofen, might have some therapeutic application in managing the" exact="disease" post="(174). The plasma angiotensin 2 level was found to"/>
 <result pre="2 level was found to be markedly elevated in COVID-19" exact="infection" post="and was correlated with viral load and lung injury."/>
 <result pre="be markedly elevated in COVID-19 infection and was correlated with" exact="viral" post="load and lung injury. Hence, drugs that block angiotensin"/>
 <result pre="that block angiotensin receptors may have potential for treating COVID-19" exact="infection" post="(121). A scientist from Germany, named Rolf Hilgenfeld, has"/>
 <result pre="on the identification of drugs for the treatment of coronaviral" exact="infection" post="since the time of the first SARS outbreak (19)."/>
 <result pre="can interact and form a six-helix bundle that brings the" exact="viral" post="and cellular membranes in close proximity, facilitating its fusion."/>
 <result pre="inhibitors target the HR1 domain of S protein, thereby preventing" exact="viral" post="fusion and entry into the host cell. This is"/>
 <result pre="role in the enhancement of host immune responses against the" exact="viral" post="agent. Inadequate nutrition is linked to the weakening of"/>
 <result pre="the individual more susceptible. The role played by nutrition in" exact="disease" post="susceptibility should be measured by evaluating the nutritional status"/>
 <result pre="emerging SARS-CoV-2, suitable animal models that can mimic the clinical" exact="disease" post="are needed (211, 212). Various animal models were assessed"/>
 <result pre="genome (219). The inability of MERS-CoV to replicate in the" exact="respiratory" post="tracts of animals (mice, hamsters, and ferrets) is another"/>
 <result pre="mice, and hDPP4-Tg mice (transgenic for expressing hDPP4) for MERS-CoV" exact="infection" post="(221). The CRISPR-Cas9 gene-editing tool has been used for"/>
 <result pre="inserting genomic alterations in mice, making them susceptible to MERS-CoV" exact="infection" post="(222). Efforts are under way to recognize suitable animal"/>
 <result pre="to counter this emerging virus. Cell lines, such as monkey" exact="epithelial" post="cell lines (LLC-MK2 and Vero-B4), goat lung cells, alpaca"/>
 <result pre="human CoVs (MERS-CoV) (223, 224). Vero and Huh-7 cells (human" exact="liver cancer" post="cells) have been used for isolating SARS-CoV-2 (194). Recently,"/>
 <result pre="CoVs (MERS-CoV) (223, 224). Vero and Huh-7 cells (human liver" exact="cancer" post="cells) have been used for isolating SARS-CoV-2 (194). Recently,"/>
 <result pre="experimental study with rhesus monkeys as animal models revealed the" exact="absence of" post="any viral loads in nasopharyngeal and anal swabs, and"/>
 <result pre="rhesus monkeys as animal models revealed the absence of any" exact="viral" post="loads in nasopharyngeal and anal swabs, and no viral"/>
 <result pre="any viral loads in nasopharyngeal and anal swabs, and no" exact="viral" post="replication was recorded in the primary tissues at a"/>
 <result pre="anal swabs, and no viral replication was recorded in the" exact="primary" post="tissues at a time interval of 5â€‰days post-reinfection in"/>
 <result pre="like the SARS-CoV-2-infected monkeys without rechallenge. These findings suggest that" exact="primary" post="infection with SARS-CoV-2 could protect from later exposures to"/>
 <result pre="the SARS-CoV-2-infected monkeys without rechallenge. These findings suggest that primary" exact="infection" post="with SARS-CoV-2 could protect from later exposures to the"/>
 <result pre="later exposures to the virus, which could help in defining" exact="disease" post="prognosis and crucial inferences for designing and developing potent"/>
 <result pre="new chapter in global health security and diplomacy. Even though" exact="complete" post="lockdown was declared following the COVID-19 outbreak in Wuhan,"/>
 <result pre="movement of people has resulted in a radiating spread of" exact="infections" post="in the surrounding provinces as well as to several"/>
 <result pre="as well as time-consuming due to the present extent of" exact="infection" post="(226). The current scenario demands effective implementation of vigorous"/>
 <result pre="and control strategies owing to the prospect of COVID-19 for" exact="nosocomial infections" post="(68). Follow-ups of infected patients by telephone on day"/>
 <result pre="control strategies owing to the prospect of COVID-19 for nosocomial" exact="infections" post="(68). Follow-ups of infected patients by telephone on day"/>
 <result pre="like face masks, will help to prevent the spread of" exact="respiratory" post="infections like COVID-19. Face masks not only protect from"/>
 <result pre="face masks, will help to prevent the spread of respiratory" exact="infections" post="like COVID-19. Face masks not only protect from infectious"/>
 <result pre="respiratory infections like COVID-19. Face masks not only protect from" exact="infectious" post="aerosols but also prevent the transmission of disease to"/>
 <result pre="protect from infectious aerosols but also prevent the transmission of" exact="disease" post="to other susceptible individuals while traveling through public transport"/>
 <result pre="(313). Another critical practice that can reduce the transmission of" exact="respiratory" post="diseases is the maintenance of hand hygiene. However, the"/>
 <result pre="the efficacy of this practice in reducing the transmission of" exact="respiratory" post="viruses like SARS-CoV-2 is much dependent upon the size"/>
 <result pre="upon the size of droplets produced. Hand hygiene will reduce" exact="disease" post="transmission only if the virus is transmitted through the"/>
 <result pre="competent enough to protect themselves and others from this deadly" exact="disease" post="(316). As a preventive measure, health care workers caring"/>
 <result pre="protection (goggles), gowns, and gloves to nullify the risk of" exact="infection" post="(299). The human-to-human transmission reported in SARS-CoV-2 infection occurs"/>
 <result pre="risk of infection (299). The human-to-human transmission reported in SARS-CoV-2" exact="infection" post="occurs mainly through droplet or direct contact. Due to"/>
 <result pre="to this finding, frontline health care workers should follow stringent" exact="infection" post="control and preventive measures, such as the use of"/>
 <result pre="preventive measures, such as the use of PPE, to prevent" exact="infection" post="(110). The mental health of the medical/health workers who"/>
 <result pre="sold in the wet market are suspected to be the" exact="intermediate" post="host of SARS-CoV-2, there is a need for strengthening"/>
 <result pre="strengthening the regulatory mechanism for wild animal trade (13). The" exact="total" post="number of COVID-19 confirmed cases is on a continuous"/>
 <result pre="continuous rise and the cure rate is relatively low, making" exact="disease" post="control very difficult to achieve. The Chinese government is"/>
 <result pre="The Chinese government is making continuous efforts to contain the" exact="disease" post="by taking emergency control and prevention measures. They have"/>
 <result pre="tracing, as well as the quarantine of people with suspected" exact="infection" post="and the isolation of infected individuals. The implementation of"/>
 <result pre="the globe. The majority of Chinese cities are now facing" exact="localized" post="outbreaks of COVID-19 (231). Hence, deploying efficient public health"/>
 <result pre="the spread of this virus globally. The occurrence of COVID-19" exact="infection" post="on several cruise ships gave us a preliminary idea"/>
 <result pre="environment and provide an ideal setting for the occurrence of" exact="respiratory" post="disease outbreaks. Such a situation poses a significant threat"/>
 <result pre="and provide an ideal setting for the occurrence of respiratory" exact="disease" post="outbreaks. Such a situation poses a significant threat to"/>
 <result pre="alternative intervention strategies, such as large-scale testing, contract tracing, and" exact="localized" post="quarantine of suspected cases for limiting the spread of"/>
 <result pre="relaxation (322). Lockdown should be imposed only to slow down" exact="disease" post="progression among the population so that the health care"/>
 <result pre="system is not overloaded. The reproduction number (R0) of COVID-19" exact="infection" post="was earlier estimated to be in the range of"/>
 <result pre="2 to 5) (93). Still, to prevent further spread of" exact="disease" post="at mass gatherings, functions remain canceled in the affected"/>
 <result pre="it is a relief that the current outbreak of COVID-19" exact="infection" post="can be brought under control with the adoption of"/>
 <result pre="Studies also report that since air traffic between China and" exact="African" post="countries increased many times over in the decade after"/>
 <result pre="many times over in the decade after the SARS outbreak," exact="African" post="countries need to be vigilant to prevent the spread"/>
 <result pre="countries should divert their resources and energy to enforcing the" exact="primary" post="level of preventive measures, like controlling the entry of"/>
 <result pre="the entry of individuals from China or countries where the" exact="disease" post="has flared up, isolating the infected individuals, and quarantining"/>
 <result pre="and quarantining individuals with suspected infection. Most of the sub-Saharan" exact="African" post="countries have a fragile health system that can be"/>
 <result pre="of COVID-19 to other countries that have not reported the" exact="disease" post="until now. The possibility of an imported case of"/>
 <result pre="hospitalization and can only be made possible by using intense" exact="disease" post="surveillance systems (235). The silent importations of infected individuals"/>
 <result pre="of clinical signs) also contributed significantly to the spread of" exact="disease" post="across the major cities of the world. Even though"/>
 <result pre="origin of SARS-CoV-2 is also suspected to be from an" exact="intermediate" post="animal host. The possibility of crossing the species barrier"/>
 <result pre="which substantially increases the probability of interspecies transmission of CoV" exact="infections" post="and could result in high risks to humans due"/>
 <result pre="expectoration, headache, and myalgia or fatigue. Individuals with asymptomatic and" exact="atypical" post="clinical manifestations were also identified recently, further adding to"/>
 <result pre="were also identified recently, further adding to the complexity of" exact="disease" post="transmission dynamics. Atypical clinical manifestations may only express symptoms"/>
 <result pre="recently, further adding to the complexity of disease transmission dynamics." exact="Atypical" post="clinical manifestations may only express symptoms such as fatigue"/>
 <result pre="manifestations may only express symptoms such as fatigue instead of" exact="respiratory" post="signs such as fever, cough, and sputum. In such"/>
 <result pre="must be vigilant for the possible occurrence of asymptomatic and" exact="atypical" post="clinical manifestations to avoid the possibility of missed diagnoses."/>
 <result pre="are typically only conducted when they are associated with specific" exact="disease" post="outbreaks. The next step following the control of the"/>
 <result pre="will help develop suitable therapeutic agents against COVID-19 in a" exact="short" post="time. Until then, we must rely exclusively on various"/>
 <result pre="on various control and prevention measures to prevent this new" exact="disease" post="from becoming a pandemic. ACKNOWLEDGMENTS All authors substantially contributed"/>
 <result pre="developed several diagnostics, vaccines, immunomodulatory modules, and hypotheses to counter" exact="infectious diseases" post="of animals, poultry, and public health concerns. He has"/>
 <result pre="interest and knowledge in the fields of veterinary medicine, pharmacology," exact="infectious diseases" post="of animals, wildlife diseases, diagnosis and therapy of animal"/>
 <result pre="as serological diagnostic testing assays. Apart from his expertise in" exact="viral" post="diagnosis, he has particular interest and knowledge in the"/>
 <result pre="he has particular interest and knowledge in the fields of" exact="infectious diseases" post="of farms, animals, and wildlife. With good academic records,"/>
 <result pre="since 2016. He has worked on the highly pathogenic H5N1" exact="avian influenza" post="virus and now is working on emerging enteric viruses"/>
 <result pre="research findings in international journals. His area of interest is" exact="infectious diseases" post="with a focus on understanding the antigenic and genetic"/>
 <result pre="on understanding the antigenic and genetic diversity of viruses causing" exact="disease" post="of several livestock species. With brilliant academic records, he"/>
 <result pre="an ICAR-National Fellow and Professor, is an expert on enteric" exact="viral" post="infections, zoonosis, and emerging viral diseases of animals and"/>
 <result pre="is an expert on enteric viral infections, zoonosis, and emerging" exact="viral" post="diseases of animals and humans. He has contributed immensely"/>
 <result pre="diseases of animals and humans. He has contributed immensely to" exact="viral" post="disease epidemiology, virus-host interactions, microbial biodiversity, characterization, and diagnosis"/>
 <result pre="of animals and humans. He has contributed immensely to viral" exact="disease" post="epidemiology, virus-host interactions, microbial biodiversity, characterization, and diagnosis of"/>
 <result pre="performed his postdoctoral work at the University of Minnesota. He" exact="acquired" post="advanced training in molecular virology from the Division of"/>
 <result pre="Singh is a veterinary pathologist. His area of interest is" exact="infectious diseases" post="with a focus on understanding the pathogenesis and molecular"/>
 <result pre="a focus on understanding the pathogenesis and molecular diagnosis of" exact="viral" post="diseases, with particular reference to rabies and bluetongue viruses."/>
 <result pre="and molecular diagnosis of viral diseases, with particular reference to" exact="rabies" post="and bluetongue viruses. Wanpen Chaicumpa, D.V.M. (Hons.), Ph.D. (microbiology),"/>
 <result pre="of the Center of Research Excellence on Therapeutic Proteins and" exact="Antibody" post="Engineering at the Department of Parasitology, Faculty of Medicine"/>
 <result pre="2019. She served as a Young Researcher, Public Health and" exact="Infection" post="Research Group, Faculty of Health Sciences, Universidad TecnolÃ³gica de"/>
 <result pre="Pereira, Risaralda, Colombia. She is a member of the Colombian" exact="Infectious" post="Diseases Association (ACIN) and the International Society for Infectious"/>
 <result pre="Risaralda, Colombia. She is a member of the Colombian Infectious" exact="Diseases" post="Association (ACIN) and the International Society for Infectious Diseases."/>
 <result pre="Colombian Infectious Diseases Association (ACIN) and the International Society for" exact="Infectious" post="Diseases. She is a member of the Committee on"/>
 <result pre="FUAM. Her main research interest is the study of zoonotic" exact="tick-borne" post="and vector-borne diseases. Alfonso J. Rodriguez-Morales, M.D., M.Sc., D.T.M."/>
 <result pre="diseases. He is President of the Travel Medicine Committee, Pan-American" exact="Infectious" post="Diseases Association (API), as well as the Vice President,"/>
 <result pre="He is President of the Travel Medicine Committee, Pan-American Infectious" exact="Diseases" post="Association (API), as well as the Vice President, Colombian"/>
 <result pre="Diseases Association (API), as well as the Vice President, Colombian" exact="Infectious" post="Diseases Association (ACIN). He is a member of the"/>
 <result pre="Association (API), as well as the Vice President, Colombian Infectious" exact="Diseases" post="Association (ACIN). He is a member of the Committee"/>
 <result pre="He is part of the Executive Board of the Latin" exact="American" post="Society for Travel Medicine (SLAMVI) and of the Council"/>
 <result pre="(SLAMVI) and of the Council of the International Society for" exact="Infectious" post="Diseases. Since 2014, he has been recognized as Senior"/>
 <result pre="Risaralda, Colombia. He is Codirector of the Public Health and" exact="Infection" post="Research Group, UTP, classified A1 by Colciencias. His Scopus"/>
 <result pre="Coronavirus Investigating and Research Team2020A novel coronavirus from patients with" exact="pneumonia" post="in China, 2019. N Engl J Med382:727â€&quot;733. doi:10.1056/NEJMoa2001017.31978945 4.WeiX,"/>
 <result pre="doi:10.1056/NEJMoa2001017.31978945 4.WeiX, LiX, CuiJ2020Evolutionary perspectives on novel coronaviruses identified in" exact="pneumonia" post="cases in China. Natl Sci Rev7:239â€&quot;242. doi:10.1093/nsr/nwaa009.32288962 5.MunsterVJ, KoopmansM,"/>
 <result pre="doi:10.1080/21645515.2016.1228500.27644155 12.Bonilla-AldanaDK, Holguin-RiveraY, Cortes-BonillaI, Cardona-TrujilloMC, GarcÃ­a-BarcoA, Bedoya-AriasHA, RabaanAA, SahR, Rodriguez-MoralesAJ622020Coronavirus" exact="infections" post="reported by ProMED, February 2000â€&quot;January 2020. Travel Med Infect"/>
 <result pre="locked-down Wuhan. Nature577:607. doi:10.1038/d41586-020-00190-6.31992886 20.DhamaK, PawaiyaRVS, ChakrabortS, TiwariR, SaminathanM, VermaAK2014Coronavirus" exact="infection" post="in equines: a review. Asian J Anim Vet Adv9:164â€&quot;176."/>
 <result pre="inhibitors. Acta Pharm70:145â€&quot;159. doi:10.2478/acph-2020-0024.31955138 22.Bonilla-AldanaDK, Villamil-GÃ³mezWE, RabaanAA, Rodriguez-MoralesAJ2020Una nueva zoonosis" exact="viral" post="de preocupaciÃ³n global: COVID-19, enfermedad por coronavirus 2019. Iatreia33:107â€&quot;110."/>
 <result pre="LaiY, HanT, LiZ, ZhouP, PanP, WangW, HuD, LiuX, ZhangQ, WuJ2020Coronavirus" exact="infections" post="and immune responses. J Med Virol92:424â€&quot;432. doi:10.1002/jmv.25685.31981224 25.collab: WHO."/>
 <result pre="and immune responses. J Med Virol92:424â€&quot;432. doi:10.1002/jmv.25685.31981224 25.collab: WHO. 2020Coronavirus" exact="disease" post="2019 (COVID-19) situation reportâ€&quot;114 (13th May, 2020). https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200513-covid-19-sitrep-114.pdf?sfvrsn=17ebbbe_4. Accessed"/>
 <result pre="BaricRS, de GrootRJ, DrostenC, GulyaevaAA, HaagmansBL, LauberC, LeontovichAM, NeumanBW, PenzarD2020Severe" exact="acute" post="respiratory syndrome-related coronavirus: the species and its virusesâ€&quot;a statement"/>
 <result pre="de GrootRJ, DrostenC, GulyaevaAA, HaagmansBL, LauberC, LeontovichAM, NeumanBW, PenzarD2020Severe acute" exact="respiratory" post="syndrome-related coronavirus: the species and its virusesâ€&quot;a statement of"/>
 <result pre="the 2019 novel human-pathogenic coronavirus isolated from a patient with" exact="atypical pneumonia" post="after visiting Wuhan. Emerg Microbes Infect9:221â€&quot;236. doi:10.1080/22221751.2020.1719902.31987001 32.BrianDA, BaricRS2005Coronavirus"/>
 <result pre="2019 novel human-pathogenic coronavirus isolated from a patient with atypical" exact="pneumonia" post="after visiting Wuhan. Emerg Microbes Infect9:221â€&quot;236. doi:10.1080/22221751.2020.1719902.31987001 32.BrianDA, BaricRS2005Coronavirus"/>
 <result pre="MommaasAM2006Ultrastructure and origin of membrane vesicles associated with the severe" exact="acute" post="respiratory syndrome coronavirus replication complex. J Virol80:5927â€&quot;5940. doi:10.1128/JVI.02501-05.16731931 35.HussainS,"/>
 <result pre="and origin of membrane vesicles associated with the severe acute" exact="respiratory" post="syndrome coronavirus replication complex. J Virol80:5927â€&quot;5940. doi:10.1128/JVI.02501-05.16731931 35.HussainS, PanJ,"/>
 <result pre="origin of membrane vesicles associated with the severe acute respiratory" exact="syndrome" post="coronavirus replication complex. J Virol80:5927â€&quot;5940. doi:10.1128/JVI.02501-05.16731931 35.HussainS, PanJ, ChenY,"/>
 <result pre="novel subgenomic RNAs and noncanonical transcription initiation signals of severe" exact="acute" post="respiratory syndrome coronavirus. J Virol79:5288â€&quot;5295. doi:10.1128/JVI.79.9.5288-5295.2005.15827143 36.MalikYS, SircarS, BhatS,"/>
 <result pre="subgenomic RNAs and noncanonical transcription initiation signals of severe acute" exact="respiratory" post="syndrome coronavirus. J Virol79:5288â€&quot;5295. doi:10.1128/JVI.79.9.5288-5295.2005.15827143 36.MalikYS, SircarS, BhatS, SharunK,"/>
 <result pre="RNAs and noncanonical transcription initiation signals of severe acute respiratory" exact="syndrome" post="coronavirus. J Virol79:5288â€&quot;5295. doi:10.1128/JVI.79.9.5288-5295.2005.15827143 36.MalikYS, SircarS, BhatS, SharunK, DhamaK,"/>
 <result pre="QinC, JinQ, CaoB, WangJW2020Identification of a novel coronavirus causing severe" exact="pneumonia" post="in human: a descriptive study. Chin Med J133:1015â€&quot;1024. doi:10.1097/CM9.0000000000000722.32004165"/>
 <result pre="and consequences of cross-species transmission. Springer, Berlin, Germany. 41.HemidaMG2019Middle East" exact="respiratory" post="syndrome coronavirus and the One Health concept. Peer J7:e7556."/>
 <result pre="consequences of cross-species transmission. Springer, Berlin, Germany. 41.HemidaMG2019Middle East respiratory" exact="syndrome" post="coronavirus and the One Health concept. Peer J7:e7556. doi:10.7717/peerj.7556.31497405"/>
 <result pre="MilletJK, LicitraBN, WhittakerGR2012Mechanisms of coronavirus cell entry mediated by the" exact="viral" post="spike protein. Viruses4:1011â€&quot;1033. doi:10.3390/v4061011.22816037 44.BeniacDR, AndonovA, GrudeskiE, BoothTF2006Architecture of"/>
 <result pre="der WerfS, YuenK-Y, AltmeyerR2005Differential maturation and subcellular localization of severe" exact="acute" post="respiratory syndrome coronavirus surface proteins S, M and E."/>
 <result pre="WerfS, YuenK-Y, AltmeyerR2005Differential maturation and subcellular localization of severe acute" exact="respiratory" post="syndrome coronavirus surface proteins S, M and E. J"/>
 <result pre="YuenK-Y, AltmeyerR2005Differential maturation and subcellular localization of severe acute respiratory" exact="syndrome" post="coronavirus surface proteins S, M and E. J Gen"/>
 <result pre="DeDiegoML, VerdiÃ¡-BÃ¡guenaC, Jimenez-GuardeÃ±oJM, Regla-NavaJA, Fernandez-DelgadoR, CastaÃ±o-RodriguezC, AlcarazA, TorresJ, AguilellaVM, EnjuanesL2014Severe" exact="acute" post="respiratory syndrome coronavirus envelope protein ion channel activity promotes"/>
 <result pre="VerdiÃ¡-BÃ¡guenaC, Jimenez-GuardeÃ±oJM, Regla-NavaJA, Fernandez-DelgadoR, CastaÃ±o-RodriguezC, AlcarazA, TorresJ, AguilellaVM, EnjuanesL2014Severe acute" exact="respiratory" post="syndrome coronavirus envelope protein ion channel activity promotes virus"/>
 <result pre="Jimenez-GuardeÃ±oJM, Regla-NavaJA, Fernandez-DelgadoR, CastaÃ±o-RodriguezC, AlcarazA, TorresJ, AguilellaVM, EnjuanesL2014Severe acute respiratory" exact="syndrome" post="coronavirus envelope protein ion channel activity promotes virus fitness"/>
 <result pre="AlvarezE, AlmazÃ¡nF, RejasMT, LamirandeE, RobertsA, ShiehWJ, ZakiSR, SubbaraoK, EnjuanesL2007A severe" exact="acute" post="respiratory syndrome corona virus that lacks the E gene"/>
 <result pre="AlmazÃ¡nF, RejasMT, LamirandeE, RobertsA, ShiehWJ, ZakiSR, SubbaraoK, EnjuanesL2007A severe acute" exact="respiratory" post="syndrome corona virus that lacks the E gene is"/>
 <result pre="RejasMT, LamirandeE, RobertsA, ShiehWJ, ZakiSR, SubbaraoK, EnjuanesL2007A severe acute respiratory" exact="syndrome" post="corona virus that lacks the E gene is attenuated"/>
 <result pre="OoiA, TanYW, WangS, FangS, LiuDX, LescarJ2005The nucleocapsid protein of coronavirus" exact="infectious" post="bronchitis virus: crystal structure of its N-terminal domain and"/>
 <result pre="TanYW, WangS, FangS, LiuDX, LescarJ2005The nucleocapsid protein of coronavirus infectious" exact="bronchitis" post="virus: crystal structure of its N-terminal domain and multimerization"/>
 <result pre="DeDiegoML, AlvarezE, HowellG, HeinenP, ZambonM, HiscoxJA2005Subcellular localization of the severe" exact="acute" post="respiratory syndrome coronavirus nucleocapsid protein. J Gen Virol86:3303â€&quot;3310. doi:10.1099/vir.0.81076-0.16298975"/>
 <result pre="AlvarezE, HowellG, HeinenP, ZambonM, HiscoxJA2005Subcellular localization of the severe acute" exact="respiratory" post="syndrome coronavirus nucleocapsid protein. J Gen Virol86:3303â€&quot;3310. doi:10.1099/vir.0.81076-0.16298975 62.CuiL,"/>
 <result pre="HowellG, HeinenP, ZambonM, HiscoxJA2005Subcellular localization of the severe acute respiratory" exact="syndrome" post="coronavirus nucleocapsid protein. J Gen Virol86:3303â€&quot;3310. doi:10.1099/vir.0.81076-0.16298975 62.CuiL, WangH,"/>
 <result pre="ZhouX, GuoD, ChenY2015The nucleocapsid protein of coronaviruses acts as a" exact="viral" post="suppressor of RNA silencing in mammalian cells. J Virol89:9029â€&quot;9043."/>
 <result pre="ZhangW, ShiZL2020Discovery of a novel coronavirus associated with the recent" exact="pneumonia" post="outbreak in humans and its potential bat origin. bioRxiv10.1101/2020.01.22.914952."/>
 <result pre="Care Med46:576â€&quot;578. doi:10.1007/s00134-020-05966-y.32077996 68.ChengVCC, WongSC, ToKKW, HoPL, YuenKY2020Preparedness and proactive" exact="infection" post="control measures against the emerging Wuhan coronavirus pneumonia in"/>
 <result pre="and proactive infection control measures against the emerging Wuhan coronavirus" exact="pneumonia" post="in China. J Hosp Infect104:254â€&quot;255. doi:10.1016/j.jhin.2020.01.010.31962139 69.LiuSL, SaifL2020Emerging viruses"/>
 <result pre="China. Int J Infect Dis91:264â€&quot;266. doi:10.1016/j.ijid.2020.01.009.31953166 72.LuH, StrattonCW, TangYW2020Outbreak of" exact="pneumonia" post="of unknown etiology in Wuhan China: the mystery and"/>
 <result pre="Med9:419. doi:10.3390/jcm9020419. 74.NishiuraH, LintonNM, AkhmetzhanovAR2020Initial cluster of novel coronavirus (2019-nCoV)" exact="infections" post="in Wuhan, China, is consistent with substantial human-to-human transmission."/>
 <result pre="WangX, WangY, GaoL2020Diagnosis, treatment, and prevention of 2019 novel coronavirus" exact="infection" post="in children: expertsâ€™ consensus statement. World J Pediatr7:1â€&quot;9. doi:10.1007/s12519-020-00343-7."/>
 <result pre="guidelines for the diagnosis and treatment of novel coronavirus (2019-nCoV)" exact="infection" post="by the National Health Commission (trial version 5). Zhonghua"/>
 <result pre="YuJ, KangM, SongY, XiaJ, GuoQ, SongT, HeJ, YenHL, PeirisM, WuJ2020SARS-CoV-2" exact="viral" post="load in upper respiratory specimens of infected patients. N"/>
 <result pre="XiaJ, GuoQ, SongT, HeJ, YenHL, PeirisM, WuJ2020SARS-CoV-2 viral load in" exact="upper" post="respiratory specimens of infected patients. N Engl J Med382:1177â€&quot;1179."/>
 <result pre="GuoQ, SongT, HeJ, YenHL, PeirisM, WuJ2020SARS-CoV-2 viral load in upper" exact="respiratory" post="specimens of infected patients. N Engl J Med382:1177â€&quot;1179. doi:10.1056/NEJMc2001737.32074444"/>
 <result pre="infected patients. N Engl J Med382:1177â€&quot;1179. doi:10.1056/NEJMc2001737.32074444 83.HaoW, LiM, HuangX1922020First" exact="atypical" post="case of 2019 novel coronavirus in Yanâ€™an, China. Clin"/>
 <result pre="novel coronavirus. Travel Med Infect Dis33:101578. doi:10.1016/j.tmaid.2020.101578.32044389 90.PeirisJS, GuanY, YuenKY2004Severe" exact="acute" post="respiratory syndrome. Nat Med10:S88â€&quot;S97. doi:10.1038/nm1143.15577937 91.HuiDS, AzharEI, KimYJ, MemishZA,"/>
 <result pre="coronavirus. Travel Med Infect Dis33:101578. doi:10.1016/j.tmaid.2020.101578.32044389 90.PeirisJS, GuanY, YuenKY2004Severe acute" exact="respiratory" post="syndrome. Nat Med10:S88â€&quot;S97. doi:10.1038/nm1143.15577937 91.HuiDS, AzharEI, KimYJ, MemishZA, OhMD,"/>
 <result pre="Nat Med10:S88â€&quot;S97. doi:10.1038/nm1143.15577937 91.HuiDS, AzharEI, KimYJ, MemishZA, OhMD, ZumlaA2018Middle East" exact="respiratory" post="syndrome coronavirus: risk factors and determinants of primary, household,"/>
 <result pre="Med10:S88â€&quot;S97. doi:10.1038/nm1143.15577937 91.HuiDS, AzharEI, KimYJ, MemishZA, OhMD, ZumlaA2018Middle East respiratory" exact="syndrome" post="coronavirus: risk factors and determinants of primary, household, and"/>
 <result pre="doi:10.23812/20-Editorial-Kritas. 93.collab: WHO. 2003Consensus document on the epidemiology of severe" exact="acute" post="respiratory syndrome (SARS). https://www.who.int/csr/sars/en/WHOconsensus.pdf. Accessed 29 January 2020. 94.DonnellyCA,"/>
 <result pre="93.collab: WHO. 2003Consensus document on the epidemiology of severe acute" exact="respiratory" post="syndrome (SARS). https://www.who.int/csr/sars/en/WHOconsensus.pdf. Accessed 29 January 2020. 94.DonnellyCA, GhaniAC,"/>
 <result pre="WHO. 2003Consensus document on the epidemiology of severe acute respiratory" exact="syndrome" post="(SARS). https://www.who.int/csr/sars/en/WHOconsensus.pdf. Accessed 29 January 2020. 94.DonnellyCA, GhaniAC, LeungGM,"/>
 <result pre="FergusonNM, AndersonRM2003Epidemiological determinants of spread of causal agent of severe" exact="acute" post="respiratory syndrome in Hong Kong. Lancet361:1761â€&quot;1766. doi:10.1016/S0140-6736(03)13410-1.12781533 95.Millan-OÃ±ateJ, RodrÃ­guez-MoralesAJ,"/>
 <result pre="AndersonRM2003Epidemiological determinants of spread of causal agent of severe acute" exact="respiratory" post="syndrome in Hong Kong. Lancet361:1761â€&quot;1766. doi:10.1016/S0140-6736(03)13410-1.12781533 95.Millan-OÃ±ateJ, RodrÃ­guez-MoralesAJ, Camacho-MorenoG,"/>
 <result pre="determinants of spread of causal agent of severe acute respiratory" exact="syndrome" post="in Hong Kong. Lancet361:1761â€&quot;1766. doi:10.1016/S0140-6736(03)13410-1.12781533 95.Millan-OÃ±ateJ, RodrÃ­guez-MoralesAJ, Camacho-MorenoG, Mendoza-RamÃ­rezH,"/>
 <result pre="(2019-nCoV) outbreak. J Travel Med27:taaa020. doi:10.1093/jtm/taaa020.32052841 97.collab: WHO. 2019Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV). https://www.who.int/en/news-room/fact-sheets/detail/middle-east-respiratory-syndromecoronavirus-(mers-cov). Accessed 29 January 2020. 98.JiangX,"/>
 <result pre="outbreak. J Travel Med27:taaa020. doi:10.1093/jtm/taaa020.32052841 97.collab: WHO. 2019Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV). https://www.who.int/en/news-room/fact-sheets/detail/middle-east-respiratory-syndromecoronavirus-(mers-cov). Accessed 29 January 2020. 98.JiangX, RaynerS,"/>
 <result pre="has killed more people than SARS and MERS combined, despite" exact="lower" post="case fatality rate. BMJ368:m641. doi:10.1136/bmj.m641.32071063 102.SongZ, XuY, BaoL, ZhangL,"/>
 <result pre="BrandJM, WidagdoW, MuÃ±ozMV, RajS, SchipperD, SolanesD, CordÃ³nI, BensaidA, HaagmansBL, SegalÃ©sJ2017Livestock" exact="susceptibility to" post="infection with Middle East respiratory syndrome coronavirus. Emerg Infect"/>
 <result pre="MuÃ±ozMV, RajS, SchipperD, SolanesD, CordÃ³nI, BensaidA, HaagmansBL, SegalÃ©sJ2017Livestock susceptibility to" exact="infection" post="with Middle East respiratory syndrome coronavirus. Emerg Infect Dis23:232â€&quot;240."/>
 <result pre="CordÃ³nI, BensaidA, HaagmansBL, SegalÃ©sJ2017Livestock susceptibility to infection with Middle East" exact="respiratory" post="syndrome coronavirus. Emerg Infect Dis23:232â€&quot;240. doi:10.3201/eid2302.161239.27901465 110.WuYC, ChenCS, ChanYJ2020Overview"/>
 <result pre="BensaidA, HaagmansBL, SegalÃ©sJ2017Livestock susceptibility to infection with Middle East respiratory" exact="syndrome" post="coronavirus. Emerg Infect Dis23:232â€&quot;240. doi:10.3201/eid2302.161239.27901465 110.WuYC, ChenCS, ChanYJ2020Overview of"/>
 <result pre="2019 novel coronavirus (2019-nCoV): the pathogen of severe specific contagious" exact="pneumonia" post="(SSCP). J Chin Med Assoc83:217â€&quot;220. doi:10.1097/JCMA.0000000000000270.32134861 111.TianHY20202019-nCoV: new challenges"/>
 <result pre="LoSK, ChanKH, PoonVK, ChanWM, IpJD, CaiJP, ChengVC, ChenH, HuiCK, YuenKY2020A" exact="familial" post="cluster of pneumonia associated with the 2019 novel coronavirus"/>
 <result pre="ChanWM, IpJD, CaiJP, ChengVC, ChenH, HuiCK, YuenKY2020A familial cluster of" exact="pneumonia" post="associated with the 2019 novel coronavirus indicating person-to-person transmission:"/>
 <result pre="doi:10.1016/S0140-6736(20)30154-9.31986261 113.BackerJA, KlinkenbergD, WallingaJ2020Incubation period of 2019 novel coronavirus (2019-nCoV)" exact="infections" post="among travellers from Wuhan, China, 20â€&quot;28 January 2020. Euro"/>
 <result pre="demographic, and clinical characteristics of 47 cases of Middle East" exact="respiratory" post="syndrome coronavirus disease from Saudi Arabia: a descriptive study."/>
 <result pre="and clinical characteristics of 47 cases of Middle East respiratory" exact="syndrome" post="coronavirus disease from Saudi Arabia: a descriptive study. Lancet"/>
 <result pre="characteristics of 47 cases of Middle East respiratory syndrome coronavirus" exact="disease" post="from Saudi Arabia: a descriptive study. Lancet Infect Dis13:752â€&quot;761."/>
 <result pre="analysis. Travel Med Infect Dis33:101566. doi:10.1016/j.tmaid.2020.101566.32007621 118.ZhouL, LiuHG2020Early detection and" exact="disease" post="assessment of patients with novel coronavirus pneumonia. Zhonghua Jie"/>
 <result pre="SongJ, XiaP, DongJ, ZhaoJ, WangF-S2020Pathological findings of COVID-19 associated with" exact="acute" post="respiratory distress syndrome. Lancet Respir Med8:420â€&quot;422. doi:10.1016/S2213-2600(20)30076-X.32085846 120.SchwartzDA, GrahamAL2020Potential"/>
 <result pre="XiaP, DongJ, ZhaoJ, WangF-S2020Pathological findings of COVID-19 associated with acute" exact="respiratory" post="distress syndrome. Lancet Respir Med8:420â€&quot;422. doi:10.1016/S2213-2600(20)30076-X.32085846 120.SchwartzDA, GrahamAL2020Potential maternal"/>
 <result pre="LiuL2020Clinical and biochemical indexes from 2019-nCoV infected patients linked to" exact="viral" post="loads and lung injury. 63:364â€&quot;374. Sci China Life Sci"/>
 <result pre="SunB, TongZH2020The keypoints in treatment of the critical novel coronavirus" exact="pneumonia" post="patient. Zhonghua Jie He He Hu Xi Za Zhi43:E022."/>
 <result pre="GaoL, WangJW, WenXJ, MaoTH, PengSW, ZhangT, ChenXM, LuFM2020Exploring the mechanism" exact="of liver" post="enzyme abnormalities in patients with novel coronavirus-infected pneumonia. Zhonghua"/>
 <result pre="J Med Virol44:152â€&quot;161. doi:10.1002/jmv.1890440207.7852955 128.TekesG, ThielHJ2016Feline coronaviruses: pathogenesis of feline" exact="infectious" post="peritonitis. Adv Virus Res96:193â€&quot;218. doi:10.1016/bs.aivir.2016.08.002.27712624 129.LicitraBN, DuhamelGE, WhittakerGR2014Canine enteric"/>
 <result pre="Adv Virus Res96:193â€&quot;218. doi:10.1016/bs.aivir.2016.08.002.27712624 129.LicitraBN, DuhamelGE, WhittakerGR2014Canine enteric coronaviruses: emerging" exact="viral" post="pathogens with distinct recombinant spike proteins. Viruses6:3363â€&quot;3376. doi:10.3390/v6083363.25153347 130.ErlesK,"/>
 <result pre="pathogens with distinct recombinant spike proteins. Viruses6:3363â€&quot;3376. doi:10.3390/v6083363.25153347 130.ErlesK, BrownlieJ2008Canine" exact="respiratory" post="coronavirus: an emerging pathogen in the canine infectious respiratory"/>
 <result pre="130.ErlesK, BrownlieJ2008Canine respiratory coronavirus: an emerging pathogen in the canine" exact="infectious" post="respiratory disease complex. Vet Clin North Am Small Anim"/>
 <result pre="BrownlieJ2008Canine respiratory coronavirus: an emerging pathogen in the canine infectious" exact="respiratory" post="disease complex. Vet Clin North Am Small Anim Pract38:815â€&quot;825."/>
 <result pre="respiratory coronavirus: an emerging pathogen in the canine infectious respiratory" exact="disease" post="complex. Vet Clin North Am Small Anim Pract38:815â€&quot;825. doi:10.1016/j.cvsm.2008.02.008.18501280"/>
 <result pre="doi:10.1016/j.cvsm.2008.02.008.18501280 131.DhamaK, SinghSD, BarathidasanR, DesinguPA, ChakrabortyS, TiwariR, KumarMA2014Emergence of avian" exact="infectious" post="bronchitis virus and its variants need better diagnosis, prevention"/>
 <result pre="131.DhamaK, SinghSD, BarathidasanR, DesinguPA, ChakrabortyS, TiwariR, KumarMA2014Emergence of avian infectious" exact="bronchitis" post="virus and its variants need better diagnosis, prevention and"/>
 <result pre="ArshadSS, OmarAR, BejoMH, AbubakarMS, AbbaY2016Pathogenesis and diagnostic approaches of avian" exact="infectious" post="bronchitis. Adv Virol2016:4621659. doi:10.1155/2016/4621659.26955391 133.WegeH, SiddellS, ter MeulenV1982The biology"/>
 <result pre="XingSZ, ChenYS, SunY, LiJ, DaszakP, WangLF, ShiZL, TongYG, MaJY2018Fatal swine" exact="acute" post="diarrhoea syndrome caused by an HKU2-related coronavirus of bat"/>
 <result pre="SunY, LiJ, DaszakP, WangLF, ShiZL, TongYG, MaJY2018Fatal swine acute diarrhoea" exact="syndrome" post="caused by an HKU2-related coronavirus of bat origin. Nature556:255â€&quot;258."/>
 <result pre="rest of the genome. Virology367:428â€&quot;439. doi:10.1016/j.virol.2007.06.009.17617433 136.BrownIH2001The pig as an" exact="intermediate" post="host for influenza A viruses between birds and humans."/>
 <result pre="doi:10.1002/jmv.25682.31967321 144.LiuP, ChenW, ChenJP2019Viral metagenomics revealed Sendai virus and coronavirus" exact="infection" post="of Malayan pangolins (Manisjavanica). Viruses11:979. doi:10.3390/v11110979. 145.XiaoK, ZhaiJ, FengY,"/>
 <result pre="ZhouJH, ZhangYZ, WangLF, DaszakP, ShiZL2018Serological evidence of bat SARS-related coronavirus" exact="infection" post="in humans, China. Virol Sin33:104â€&quot;107. doi:10.1007/s12250-018-0012-7.29500691 148.GaoZC2020Efficient management of"/>
 <result pre="humans, China. Virol Sin33:104â€&quot;107. doi:10.1007/s12250-018-0012-7.29500691 148.GaoZC2020Efficient management of novel coronavirus" exact="pneumonia" post="by efficient prevention and control in scientific manner. Zhonghua"/>
 <result pre="2019 novel coronavirus infection: proposal of conventional serologic assays for" exact="disease" post="diagnosis and infection monitoring. J Med Virol92:464â€&quot;467. doi:10.1002/jmv.25702.32031264 150.YuF,"/>
 <result pre="infection: proposal of conventional serologic assays for disease diagnosis and" exact="infection" post="monitoring. J Med Virol92:464â€&quot;467. doi:10.1002/jmv.25702.32031264 150.YuF, DuL, OjciusDM, PanC,"/>
 <result pre="doi:10.1002/jmv.25702.32031264 150.YuF, DuL, OjciusDM, PanC, JiangS2020Measures for diagnosing and treating" exact="infections" post="by a novel coronavirus responsible for a pneumonia outbreak"/>
 <result pre="and treating infections by a novel coronavirus responsible for a" exact="pneumonia" post="outbreak originating in Wuhan, China. Microbes Infect22:74â€&quot;79. doi:10.1016/j.micinf.2020.01.003.32017984 151.PanY,"/>
 <result pre="negative RT-PCR testing. Radiology doi:10.1148/radiol.2020200343. 155.BinnickerMJ2020Emergence of a novel coronavirus" exact="disease" post="(COVID-19) and the importance of diagnostic testing: why partnership"/>
 <result pre="PengW, WangW, ChenX2020Therapeutic and triage strategies for 2019 novel coronavirus" exact="disease" post="in fever clinics. Lancet Respir Med8:e11â€&quot;e12. doi:10.1016/S2213-2600(20)30071-0.32061335 159.ShiH, HanX,"/>
 <result pre="AlwalidO, GuJ, FanY, ZhengC2020Radiological findings from 81 patients with COVID-19" exact="pneumonia" post="in Wuhan, China: a descriptive study. Lancet Infect Dis20:425â€&quot;434."/>
 <result pre="efficient, dual-use vaccine for humans and animals against Middle East" exact="Respiratory" post="syndrome coronavirus and rabies virus. J Virol91:e02040-16. doi:10.1128/JVI.02040-16.27807241 170.BuchholzUJ,"/>
 <result pre="dual-use vaccine for humans and animals against Middle East Respiratory" exact="syndrome" post="coronavirus and rabies virus. J Virol91:e02040-16. doi:10.1128/JVI.02040-16.27807241 170.BuchholzUJ, BukreyevA,"/>
 <result pre="humans and animals against Middle East Respiratory syndrome coronavirus and" exact="rabies" post="virus. J Virol91:e02040-16. doi:10.1128/JVI.02040-16.27807241 170.BuchholzUJ, BukreyevA, YangL, LamirandeEW, MurphyBR,"/>
 <result pre="LamirandeEW, MurphyBR, SubbaraoK, CollinsPL2004Contributions of the structural proteins of severe" exact="acute" post="respiratory syndrome coronavirus to protective immunity. Proc Natl Acad"/>
 <result pre="MurphyBR, SubbaraoK, CollinsPL2004Contributions of the structural proteins of severe acute" exact="respiratory" post="syndrome coronavirus to protective immunity. Proc Natl Acad Sci"/>
 <result pre="SubbaraoK, CollinsPL2004Contributions of the structural proteins of severe acute respiratory" exact="syndrome" post="coronavirus to protective immunity. Proc Natl Acad Sci U"/>
 <result pre="MERS-CoV. Antiviral Res137:82â€&quot;92. doi:10.1016/j.antiviral.2016.11.006.27840203 173.JiangS, DuL, ShiZ2020An emerging coronavirus causing" exact="pneumonia" post="outbreak in Wuhan, China: calling for developing therapeutic and"/>
 <result pre="recombinant adenovirus-based vaccine expressing full-length spike protein of Middle East" exact="respiratory" post="syndrome coronavirus. PLoS One14:e0220196. doi:10.1371/journal.pone.0220196.31329652 178.ShiJ, ZhangJ, LiS, SunJ,"/>
 <result pre="adenovirus-based vaccine expressing full-length spike protein of Middle East respiratory" exact="syndrome" post="coronavirus. PLoS One14:e0220196. doi:10.1371/journal.pone.0220196.31329652 178.ShiJ, ZhangJ, LiS, SunJ, TengY,"/>
 <result pre="highly pathogenic MERS-CoV: an in silico approach applied to emerging" exact="infectious diseases." post="PLoS One10:e0144475. doi:10.1371/journal.pone.0144475.26641892 179.XieQ, HeX, YangF, LiuX, LiY, LiuY,"/>
 <result pre="of B-cell epitopes of the envelope protein of Middle East" exact="respiratory" post="syndrome-coronavirus. IEEE/ACM Trans Comput Biol Bioinform15:1344â€&quot;1350. doi:10.1109/TCBB.2017.2702588.28574363 180.collab: NIAID."/>
 <result pre="2020. 183.AdedejiAO, SeversonW, JonssonC, SinghK, WeissSR, SarafianosSG2013Novel inhibitors of severe" exact="acute" post="respiratory syndrome coronavirus entry that act by three distinct"/>
 <result pre="183.AdedejiAO, SeversonW, JonssonC, SinghK, WeissSR, SarafianosSG2013Novel inhibitors of severe acute" exact="respiratory" post="syndrome coronavirus entry that act by three distinct mechanisms."/>
 <result pre="SeversonW, JonssonC, SinghK, WeissSR, SarafianosSG2013Novel inhibitors of severe acute respiratory" exact="syndrome" post="coronavirus entry that act by three distinct mechanisms. J"/>
 <result pre="rhesus macaques. Nat Med19:1313â€&quot;1317. doi:10.1038/nm.3362.24013700 185.LuL, LiuQ, DuL, JiangS2013Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV): challenges in identifying its source and"/>
 <result pre="macaques. Nat Med19:1313â€&quot;1317. doi:10.1038/nm.3362.24013700 185.LuL, LiuQ, DuL, JiangS2013Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV): challenges in identifying its source and controlling"/>
 <result pre="QinC, YuenKY2015Treatment with lopinavir/ritonavir or interferon-Î²1b improves outcome of MERS-CoV" exact="infection" post="in a nonhuman primate model of common Marmoset. J"/>
 <result pre="FowlerRA, HaydenFG, HusseinMA, collab: MIRACLE Trial Group2018Treatment of Middle East" exact="respiratory" post="syndrome with a combination of lopinavir-ritonavir and interferon-Î²1b (MIRACLE"/>
 <result pre="HaydenFG, HusseinMA, collab: MIRACLE Trial Group2018Treatment of Middle East respiratory" exact="syndrome" post="with a combination of lopinavir-ritonavir and interferon-Î²1b (MIRACLE trial):"/>
 <result pre="controlled trial. Trials19:81. doi:10.1186/s13063-017-2427-0.29382391 192.collab: WHO. 2020Clinical management of severe" exact="acute" post="respiratory infection when novel coronavirus (nCoV) infection is suspected."/>
 <result pre="trial. Trials19:81. doi:10.1186/s13063-017-2427-0.29382391 192.collab: WHO. 2020Clinical management of severe acute" exact="respiratory" post="infection when novel coronavirus (nCoV) infection is suspected. Available"/>
 <result pre="Trials19:81. doi:10.1186/s13063-017-2427-0.29382391 192.collab: WHO. 2020Clinical management of severe acute respiratory" exact="infection" post="when novel coronavirus (nCoV) infection is suspected. Available onhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected."/>
 <result pre="management of severe acute respiratory infection when novel coronavirus (nCoV)" exact="infection" post="is suspected. Available onhttps://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected. Accessed on 7 February 2020."/>
 <result pre="and therapeutic procedure for four cases with 2019 novel coronavirus" exact="pneumonia" post="receiving combined Chinese and Western medicine treatment. Biosci Trends14:64â€&quot;68."/>
 <result pre="KsiazekTG, SeidahNG, NicholST2005Chloroquine is a potent inhibitor of SARS coronavirus" exact="infection" post="and spread. Virol J2:69. doi:10.1186/1743-422X-2-69.16115318 197.GaoJ, TianZ, YangX2020Breakthrough: chloroquine"/>
 <result pre="phosphate has shown apparent efficacy in treatment of COVID-19 associated" exact="pneumonia" post="in clinical studies. Biosci Trends14:72â€&quot;73. doi:10.5582/bst.2020.01047.32074550 198.WidjajaI, WangC, van"/>
 <result pre="immune serum in an experimental animal model for Middle East" exact="respiratory" post="syndrome coronavirus infection. J Virol89:6117â€&quot;6120. doi:10.1128/JVI.00446-15.25787284 205.ZhangL, LiuY2020Potential interventions"/>
 <result pre="serum in an experimental animal model for Middle East respiratory" exact="syndrome" post="coronavirus infection. J Virol89:6117â€&quot;6120. doi:10.1128/JVI.00446-15.25787284 205.ZhangL, LiuY2020Potential interventions for"/>
 <result pre="doi:10.1128/JVI.00446-15.25787284 205.ZhangL, LiuY2020Potential interventions for novel coronavirus in China: a" exact="systemic" post="review. J Med Virol92:479â€&quot;490. doi:10.1002/jmv.25707.32052466 206.SeesuayW, JittavisutthikulS, Sae-LimN, SookrungN,"/>
 <result pre="FDA-approved compound library identifies four small-molecule inhibitors of Middle East" exact="respiratory" post="syndrome coronavirus replication in cell culture. Antimicrob Agents Chemother58:4875â€&quot;4884."/>
 <result pre="compound library identifies four small-molecule inhibitors of Middle East respiratory" exact="syndrome" post="coronavirus replication in cell culture. Antimicrob Agents Chemother58:4875â€&quot;4884. doi:10.1128/AAC.03011-14.24841269"/>
 <result pre="HoKL, TanWS2019Recent advances in the vaccine development against Middle East" exact="respiratory" post="syndrome-coronavirus. Front Microbiol10:1781. doi:10.3389/fmicb.2019.01781.31428074 213.MartinaBE, HaagmansBL, KuikenT, FouchierRA, RimmelzwaanGF,"/>
 <result pre="HaagmansBL, KuikenT, FouchierRA, RimmelzwaanGF, Van AmerongenG, PeirisJS, LimW, OsterhausAD2003Virology: SARS" exact="virus infection" post="of cats and ferrets. Nature425:915. doi:10.1038/425915a.14586458 214.LamirandeEW, DeDiegoML, RobertsA,"/>
 <result pre="KuikenT, FouchierRA, RimmelzwaanGF, Van AmerongenG, PeirisJS, LimW, OsterhausAD2003Virology: SARS virus" exact="infection" post="of cats and ferrets. Nature425:915. doi:10.1038/425915a.14586458 214.LamirandeEW, DeDiegoML, RobertsA,"/>
 <result pre="AlvarezE, SheahanT, ShiehWJ, ZakiSR, BaricR, EnjuanesL, SubbaraoK2008A live attenuated severe" exact="acute" post="respiratory syndrome coronavirus is immunogenic and efficacious in golden"/>
 <result pre="SheahanT, ShiehWJ, ZakiSR, BaricR, EnjuanesL, SubbaraoK2008A live attenuated severe acute" exact="respiratory" post="syndrome coronavirus is immunogenic and efficacious in golden Syrian"/>
 <result pre="ShiehWJ, ZakiSR, BaricR, EnjuanesL, SubbaraoK2008A live attenuated severe acute respiratory" exact="syndrome" post="coronavirus is immunogenic and efficacious in golden Syrian hamsters."/>
 <result pre="ZhuJ, McLellanJS, ScottDP, KatzeMG, FeldmannH, MunsterVJ2014Infection with MERS-CoV causes lethal" exact="pneumonia" post="in the common marmoset. PLoS Pathog10:e1004250. doi:10.1371/journal.ppat.1004250.25144235 217.DuL, TaiW,"/>
 <result pre="Med57:450â€&quot;459.17974127 220.LeistSR, CockrellAS2020Genetically engineering a susceptible mouse model for MERS-CoV-induced" exact="acute" post="respiratory distress syndrome. Methods Mol Biol2099:137â€&quot;159. doi:10.1007/978-1-0716-0211-9_12.31883094 221.ZhouY, JiangS,"/>
 <result pre="220.LeistSR, CockrellAS2020Genetically engineering a susceptible mouse model for MERS-CoV-induced acute" exact="respiratory" post="distress syndrome. Methods Mol Biol2099:137â€&quot;159. doi:10.1007/978-1-0716-0211-9_12.31883094 221.ZhouY, JiangS, DuL2018Prospects"/>
 <result pre="BeallA, TangXC, MarascoWA, HeiseMT, BaricRS2016A mouse model for MERS coronavirus-induced" exact="acute" post="respiratory distress syndrome. Nat Microbiol2:16226. doi:10.1038/nmicrobiol.2016.226.27892925 223.EckerleI, CormanVM, MÃ¼llerMA,"/>
 <result pre="TangXC, MarascoWA, HeiseMT, BaricRS2016A mouse model for MERS coronavirus-induced acute" exact="respiratory" post="distress syndrome. Nat Microbiol2:16226. doi:10.1038/nmicrobiol.2016.226.27892925 223.EckerleI, CormanVM, MÃ¼llerMA, LenkM,"/>
 <result pre="Infect104:252â€&quot;253. doi:10.1016/j.jhin.2020.01.019.32032614 227.SunK, ChenJ, ViboudC2020Early epidemiological analysis of the coronavirus" exact="disease" post="2019 outbreak based on crowdsourced data: a population-level observational"/>
 <result pre="outbreak based on crowdsourced data: a population-level observational study. Lancet" exact="Digital" post="Health2:e201â€&quot;e208. doi:10.1016/S2589-7500(20)30026-1.32309796 228.TangB, WangX, LiQ, BragazziNL, TangS, XiaoY, WuJ2020Estimation"/>
 <result pre="XuX, WangX, CowlingBJ, MeyersLA2020Risk for transportation of 2019 novel coronavirus" exact="disease" post="from Wuhan to other cities in China. Emerg Infect"/>
 <result pre="HouW, ZhangY2020Clinical characteristics and intrauterine vertical transmission potential of COVID-19" exact="infection" post="in nine pregnant women: a retrospective review of medical"/>
 <result pre="LiuH, DengD, ChenS, ZengW, FengL, WuJ2020Clinical features and obstetric and" exact="neonatal" post="outcomes of pregnant patients with COVID-19 in Wuhan, China:"/>
 <result pre="Valle-ReconcoJA, SierraM, Bonilla-AldanaDK, Cardona-OspinaJA, RodrÃ­guez-MoralesAJ2532020A pregnant woman with COVID-19 in" exact="Central" post="America. Travel Med Infect Dis doi:10.1016/j.tmaid.2020.101639. 244.Rodriguez-MoralesAJ, Cardona-OspinaJA, GutiÃ©rrez-OcampoE,"/>
 <result pre="Balbin-RamonGJ, RabaanAA, HarapanH, DhamaK, NishiuraH, KataokaH, AhmadT, SahR, collab: Latin" exact="American" post="Network of Coronavirus Disease 2019-COVID-19 Research (LANCOVID-19)2020Clinical, laboratory and"/>
 <result pre="NishiuraH, KataokaH, AhmadT, SahR, collab: Latin American Network of Coronavirus" exact="Disease" post="2019-COVID-19 Research (LANCOVID-19)2020Clinical, laboratory and imaging features of COVID-19:"/>
 <result pre="MaiwaldM, LiJ, ChongCY, NaduaK, TanNWH, ThoonKC2822020A well infant with coronavirus" exact="disease" post="2019 with high viral load. Clin Infect Dis doi:10.1093/cid/ciaa201."/>
 <result pre="TanNWH, ThoonKC2822020A well infant with coronavirus disease 2019 with high" exact="viral" post="load. Clin Infect Dis doi:10.1093/cid/ciaa201. 248.WoelfelR, CormanVM, GuggemosW, SeilmaierM,"/>
 <result pre="WendtnerC2020Clinical presentation and virological assessment of hospitalized cases of coronavirus" exact="disease" post="2019 in a travel-associated transmission cluster. medRxiv10.1101/2020.03.05.20030502. 249.HeY, WangZ,"/>
 <result pre="Hepatol5:430â€&quot;432. doi:10.1016/S2468-1253(20)30082-0.32192627 251.XiaoF, TangM, ZhengX, LiuY, LiX, ShanH2020Evidence for gastrointestinal" exact="infection" post="of SARS-CoV-2. Gastroenterology158:1831â€&quot;1833. doi:10.1053/j.gastro.2020.02.055.32142773 252.YeoC, KaushalS, YeoD2020Enteric involvement of"/>
 <result pre="KimJM, ChungYS, KimHM, HanMG, KimSY, ChinBS2020Viral load kinetics of SARS-CoV-2" exact="infection" post="in first two patients in Korea. J Korean Med"/>
 <result pre="Microbes Infect9:1â€&quot;26. doi:10.1080/22221751.2020.1745095.31859589 259.collab: US Food and Drug Administration. 2020Coronavirus" exact="disease" post="(COVID-19) Emergency Use Authorization (EUA) informationâ€&quot;in vitro diagnostic EUAs."/>
 <result pre="J Antimicrob Agents55:105938. doi:10.1016/j.ijantimicag.2020.105938.32171740 264.SahraeiZ, ShabaniM, ShokouhiS, SaffaeiA2020Aminoquinolines against coronavirus" exact="disease" post="2019 (COVID-19): chloroquine or hydroxychloroquine. Int J Antimicrob Agents55:105945."/>
 <result pre="optimized dosing design of hydroxychloroquine for the treatment of severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis doi:10.1093/cid/ciaa237."/>
 <result pre="dosing design of hydroxychloroquine for the treatment of severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis doi:10.1093/cid/ciaa237. 267.ZhouD,"/>
 <result pre="design of hydroxychloroquine for the treatment of severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2). Clin Infect Dis doi:10.1093/cid/ciaa237. 267.ZhouD, DaiSM,"/>
 <result pre="a recommendation to examine the effect of hydroxychloroquine in preventing" exact="infection" post="and progression. J Antimicrob Chemother doi:10.1093/jac/dkaa114. 268.SrinivasaA, TosounidouS, GordonC2017Increased"/>
 <result pre="272.KeyaertsE, VijgenL, MaesP, NeytsJ, Van RanstM2004In vitro inhibition of severe" exact="acute" post="respiratory syndrome coronavirus by chloroquine. Biochem Biophys Res Commun323:264â€&quot;268."/>
 <result pre="VijgenL, MaesP, NeytsJ, Van RanstM2004In vitro inhibition of severe acute" exact="respiratory" post="syndrome coronavirus by chloroquine. Biochem Biophys Res Commun323:264â€&quot;268. doi:10.1016/j.bbrc.2004.08.085.15351731"/>
 <result pre="MaesP, NeytsJ, Van RanstM2004In vitro inhibition of severe acute respiratory" exact="syndrome" post="coronavirus by chloroquine. Biochem Biophys Res Commun323:264â€&quot;268. doi:10.1016/j.bbrc.2004.08.085.15351731 273.CaoB,"/>
 <result pre="in SARS-CoV-2 infected rhesus macaques. bioRxiv10.1101/2020.03.13.990226. 275.ChengVC, LauSK, WooPC, YuenKY2007Severe" exact="acute" post="respiratory syndrome coronavirus as an agent of emerging and"/>
 <result pre="SARS-CoV-2 infected rhesus macaques. bioRxiv10.1101/2020.03.13.990226. 275.ChengVC, LauSK, WooPC, YuenKY2007Severe acute" exact="respiratory" post="syndrome coronavirus as an agent of emerging and reemerging"/>
 <result pre="infected rhesus macaques. bioRxiv10.1101/2020.03.13.990226. 275.ChengVC, LauSK, WooPC, YuenKY2007Severe acute respiratory" exact="syndrome" post="coronavirus as an agent of emerging and reemerging infection."/>
 <result pre="emerging and reemerging infection. Clin Microbiol Rev20:660â€&quot;694. doi:10.1128/CMR.00023-07.17934078 276.IsonMG, HirschHH2019Community-acquired" exact="respiratory" post="viruses in transplant patients: diversity, impact, unmet clinical needs."/>
 <result pre="doi:10.1128/CMR.00042-19. 277.SanchezJL, CooperMJ, MyersCA, CummingsJF, VestKG, RussellKL, SanchezJL, HiserMJ, GaydosCA2015Respiratory" exact="infections" post="in the U.S. military: recent experience and control. Clin"/>
 <result pre="Microbiol Rev28:743â€&quot;800. doi:10.1128/CMR.00039-14.26085551 278.ChanJF, LauSK, ToKK, ChengVC, WooPC, YuenKY2015Middle East" exact="respiratory" post="syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin"/>
 <result pre="Rev28:743â€&quot;800. doi:10.1128/CMR.00039-14.26085551 278.ChanJF, LauSK, ToKK, ChengVC, WooPC, YuenKY2015Middle East respiratory" exact="syndrome" post="coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol"/>
 <result pre="A/2009/H1N1: what have we learned?Clin Microbiol Rev25:223â€&quot;263. doi:10.1128/CMR.05012-11.22491771 280.Gillim-RossL, SubbaraoK2006Emerging" exact="respiratory" post="viruses: challenges and vaccine strategies. Clin Microbiol Rev19:614â€&quot;636. doi:10.1128/CMR.00005-06.17041137"/>
 <result pre="pathogenesis, immunopathology and mitigation strategiesâ€&quot;a review. Preprintshttps://www.preprints.org/manuscript/202003.0348/v1. 283.KimberlinDW, StagnoS2632020Can SARS-CoV-2" exact="infection" post="be acquired in utero? More definitive evidence is needed."/>
 <result pre="and mitigation strategiesâ€&quot;a review. Preprintshttps://www.preprints.org/manuscript/202003.0348/v1. 283.KimberlinDW, StagnoS2632020Can SARS-CoV-2 infection be" exact="acquired" post="in utero? More definitive evidence is needed. JAMA doi:10.1001/jama.2020.4868."/>
 <result pre="MarimuthuK2020Air, surface environmental, and personal protective equipment contamination by severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient."/>
 <result pre="surface environmental, and personal protective equipment contamination by severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA323:1610."/>
 <result pre="environmental, and personal protective equipment contamination by severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) from a symptomatic patient. JAMA323:1610. doi:10.1001/jama.2020.3227.32129805"/>
 <result pre="by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from a" exact="symptomatic" post="patient. JAMA323:1610. doi:10.1001/jama.2020.3227.32129805 290.ZhangT, CuiX, ZhaoX, WangJ, ZhengJ, ZhengG,"/>
 <result pre="CuiX, ZhaoX, WangJ, ZhengJ, ZhengG, GuoW, CaiC, HeS, XuY2932020Detectable SARS-CoV-2" exact="viral" post="RNA in feces of three children during recovery period"/>
 <result pre="WangS, MaC, XieR, WangF, TanC, ZhuL, GuoY, ZhangF2832020Quantitative detection and" exact="viral" post="load analysis of SARS-CoV-2 in infected patients. Clin Infect"/>
 <result pre="anti-inflammatory drugs in the treatment of people with severe coronavirus" exact="disease" post="2019 (COVID-19): the experience of clinical immunologists from China."/>
 <result pre="guidelines on the management of critically ill adults with coronavirus" exact="disease" post="2019 (COVID-19). Intensive Care Med46:854â€&quot;887. doi:10.1007/s00134-020-06022-5.32222812 304.AtluriS, ManchikantiL, HirschJA2020Expanded"/>
 <result pre="318.MalikYS, SircarS, BhatS, VinodhkumarOR, TiwariR, SahR, RabaanAA, Rodriguez-MoralesAJ, DhamaK2020Emerging coronavirus" exact="disease" post="(COVID-19), a pandemic public health emergency with animal linkages:"/>
 <result pre="NagiN, AgarwalA, DasB, BanerjeeS, SarkarS, GuptaN, GangakhedkarRR2020The 2019 novel coronavirus" exact="disease" post="(COVID-19) pandemic: a review of the current evidence. Indian"/>
 <result pre="for the wastewater surveillance of COVID-19 in the community. Sci" exact="Total" post="Environ728:138764. doi:10.1016/j.scitotenv.2020.138764.32387778 328.NÃºÃ±ez-DelgadoA2020What do we know about the SARS-CoV-2"/>
 <result pre="do we know about the SARS-CoV-2 coronavirus in the environment?Sci" exact="Total" post="Environ727:138647. doi:10.1016/j.scitotenv.2020.138647.32315907 329.ShiJ, WenZ, ZhongG, YangH, WangC, HuangB, LiuR,"/>
 <result pre="2020SARS-CoV-2 in animals. https://www.avma.org/resources-tools/animal-health-and-welfare/covid-19/sars-cov-2-animals-including-pets. Accessed 11 May 2020. 336.OpriessnigT, HuangYW2020Coronavirus" exact="disease" post="2019 (COVID-19) outbreak: could pigs be vectors for human"/>
 <result pre="PapenburgJ, DesjardinsM, KanjilalS, QuachC, LibmanM, DittrichS, YansouniCP1352020Diagnostic testing for severe" exact="acute" post="respiratory syndrome-related coronavirus-2: a narrative review. Ann Intern Med13:M20-1301."/>
 <result pre="DesjardinsM, KanjilalS, QuachC, LibmanM, DittrichS, YansouniCP1352020Diagnostic testing for severe acute" exact="respiratory" post="syndrome-related coronavirus-2: a narrative review. Ann Intern Med13:M20-1301. doi:10.7326/M20-1301."/>
 <result pre="XuQ, FangX, ZhangS, XiaJ, XiaJ1932020Artificial intelligence distinguishes COVID-19 from community" exact="acquired" post="pneumonia on chest CT. Radiology doi:10.1148/radiol.2020200905. 349.LuR, WuX, WanZ,"/>
 <result pre="FangX, ZhangS, XiaJ, XiaJ1932020Artificial intelligence distinguishes COVID-19 from community acquired" exact="pneumonia" post="on chest CT. Radiology doi:10.1148/radiol.2020200905. 349.LuR, WuX, WanZ, LiY,"/>
 <result pre="XiaJ, XiaJ1932020Artificial intelligence distinguishes COVID-19 from community acquired pneumonia on" exact="chest" post="CT. Radiology doi:10.1148/radiol.2020200905. 349.LuR, WuX, WanZ, LiY, ZuoL, QinJ,"/>
 <result pre="KozlowskiHN, MalekjahaniA, OsborneM, LiVYC, ChenH, MubarekaS, GubbayJB, ChanW2020Diagnosing COVID-19: the" exact="disease" post="and tools for detection. ACS Nano14:3822â€&quot;3835. doi:10.1021/acsnano.0c02624.32223179 352.VashistSK2020In vitro"/>
 <result pre="Lancet395:e48. doi:10.1016/S0140-6736(20)30466-9.32113506 358.Kamel BoulosMN, GeraghtyEM2020Geographical tracking and mapping of coronavirus" exact="disease" post="COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and"/>
 <result pre="358.Kamel BoulosMN, GeraghtyEM2020Geographical tracking and mapping of coronavirus disease COVID-19/severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events"/>
 <result pre="BoulosMN, GeraghtyEM2020Geographical tracking and mapping of coronavirus disease COVID-19/severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around"/>
 <result pre="GeraghtyEM2020Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) epidemic and associated events around the"/>
</results>
